Bell's palsy

G6_BELLPA

Bell's palsy: Partial or complete paralysis of the facial muscles of one side of a person's face. It is caused by damage to the seventh cranial nerve. It is usually temporary but it may recur.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G51.0 Hospital discharge: ICD-9 — 3510A Hospital discharge: ICD-8 — 350 Cause of death: ICD-10 — G51.0 Cause of death: ICD-9 — 3510A Cause of death: ICD-8 — 350 2 out of 7 registries used, show all original rules.	5005
4. Check minimum number of events None	5005
5. Include endpoints None	5005
6. Filter based on genotype QC (FinnGen only)	5005

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G51
Name in latin: Paresis nervi facialis

NAME	G6_BELLPA
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G510
HD_ICD_9	3510A
HD_ICD_8	350
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G510
COD_ICD_9	3510A
COD_ICD_8	350
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bell's palsy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	41280	21652	19358
Only index persons	36873	19506	17367
Unadjusted period prevalence (%)
Whole population	0.58	0.62	0.54
Only index persons	0.69	0.72	0.66
Median age at first event (years)
Whole population	51.87	52.85	50.80
Only index persons	50.32	51.08	49.47

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5005	2834	2171
Unadjusted period prevalence (%)	0.96	0.97	0.96
Median age at first event (years)	53.04	50.39	56.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4467: Matched controls
44669

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

4.4

323.0

2963

13855

G51.0

ICD-10 Finland

Bell palsy

16384.0

323.0

4118

G56.0

ICD-10 Finland

Carpal tunnel syndrome

10.5

206.8

422

438

ACC51

NOMESCO Finland

Release of median nerve

86.9

185.1

207

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

151.5

2062

11955

3510A

ICD-9 Finland

Facial nerve disorders, Bell's palsy

+∞

131.9

126

35008

ICD-8 Finland

Facial paralysis, Alia definita

+∞

125.6

120

H02.2

ICD-10 Finland

Lagophthalmos

53.1

119.9

144

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

561.7

111.4

110

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

31.4

106.7

143

AA1AD

NOMESCO Finland

CT of head and brain

2.2

94.3

1143

5941

N91

ICPC

Facial paralysis/bell's palsy

245.1

93.9

G51.9

ICD-10 Finland

Disorder of facial nerve, unspecified

323.0

93.2

TAB00

NOMESCO Finland

Lumbar puncture

4.6

92.1

339

778

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

82.1

472

1582

35009

ICD-8 Finland

Facial paralysis, Unspecified

+∞

78.3

N03AX16

ATC

pregabalin; oral

2.1

67.4

974

5344

35000

ICD-8 Finland

+∞

63.7

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.3

63.1

648

3043

N03AX12

ATC

gabapentin; oral

2.3

62.7

631

2933

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

62.5

1112

6585

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

60.9

975

5540

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

60.3

1015

5874

UDC00

NOMESCO Finland

Ear microscopy

2.9

59.2

390

1426

A10BA02

ATC

metformin; oral

1.8

56.8

1137

6979

G50.1

ICD-10 Finland

Atypical facial pain

13.0

55.1

A10AE04

ATC

insulin glargine; parenteral

2.6

53.7

430

1764

G50.0

ICD-10 Finland

Trigeminal neuralgia

14.2

49.4

A02BC02

ATC

pantoprazole; systemic

1.6

49.0

2659

21398

DFF00

NOMESCO Finland

Pure tone audiometry

2.4

47.8

436

1912

J01DB01

ATC

cefalexin; oral

1.7

47.6

3474

30100

N02AX02

ATC

tramadol; systemic, rectal

1.6

46.7

1658

11922

R51.80

ICD-10 Finland

Headache

2.1

46.5

610

3167

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

44.7

445

2039

QAJ10

NOMESCO Finland

Browlift

25.7

43.7

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.6

43.2

336

1350

H53.2

ICD-10 Finland

Diplopia

4.0

42.8

179

462

T90

ICPC

Diabetes non-insulin dependent

1.8

42.1

898

5545

D33.30

ICD-10 Finland

Acoustic neuroma

10.1

42.0

G51.3

ICD-10 Finland

Clonic hemifacial spasm

+∞

41.7

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

33.5

40.7

CBH25

NOMESCO Finland

Tarsorrhaphy

66.3

40.1

G56.2

ICD-10 Finland

Lesion of ulnar nerve

9.4

39.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

39.0

1705

12739

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

37.9

414

1975

R42

ICD-10 Finland

Dizziness and giddiness

1.7

37.9

858

5373

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.7

37.8

173

483

N02BE01

ATC

paracetamol; systemic, rectal

1.6

37.6

3590

31959

G54.0

ICD-10 Finland

Brachial plexus disorders

10.7

36.5

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

36.1

314

1340

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

8.5

35.2

J05AB11

ATC

valaciclovir; oral

1.9

35.2

572

3205

H02.4

ICD-10 Finland

Ptosis of eyelid

3.8

33.9

149

402

H02.1

ICD-10 Finland

Ectropion of eyelid

7.5

33.7

110

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

33.6

358

1687

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

33.3

2199

17769

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

32.7

278

1171

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

32.5

1765

13663

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

9.2

32.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

31.9

344

1628

ZZC00

NOMESCO Finland

Graft of fascia

34.5

31.8

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

31.7

216

801

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

5.3

30.7

181

A69.2

ICD-10 Finland

Lyme disease

2.6

30.7

234

929

A10BB12

ATC

glimepiride; oral

2.3

30.4

292

1310

TAC00

NOMESCO Finland

Peripheral nerve block

16.0

30.2

J01AA02

ATC

doxycycline; systemic

1.5

29.4

3178

27985

WX110

NOMESCO Finland

Local anesthesy

1.4

29.1

2750

23547

J01DA01

ATC

[U] cefalexin; systemic

1.4

28.9

2518

21218

QAJ20

NOMESCO Finland

Subperiosteal facelift

293.8

28.8

G51

ICD-10 Finland

Facial nerve disorders

293.8

28.8

CBH30

NOMESCO Finland

Tarsorraphy

151.0

28.7

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

28.6

191

702

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

15.3

28.6

SPAT1262

SPAT

Handing over of treatment supplies

1.7

28.4

684

4324

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

28.2

571

3427

G51.8

ICD-10 Finland

Other disorders of facial nerve

+∞

28.1

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

13.0

27.8

M79.6

ICD-10 Finland

Pain in limb

1.5

27.8

1312

9778

H02.3

ICD-10 Finland

Blepharochalasis

2.3

27.1

256

1139

CBF10

NOMESCO Finland

Shortening of canthal ligaments and tarsal plate for ectropion

18.8

26.9

A10BH01

ATC

sitagliptin; oral

2.0

26.9

365

1901

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

26.5

347

1782

A10AE05

ATC

insulin detemir; parenteral

2.4

26.2

222

935

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

26.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

25.8

1023

7321

AAH50

NOMESCO Finland

Cranial nerve anastomosis

262.1

25.7

ACC53

NOMESCO Finland

Release of ulnar nerve

50.3

25.2

C08CA01

ATC

amlodipine; oral

1.5

25.2

1304

9861

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

24.8

191

763

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

24.7

620

3953

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

24.6

407

2280

H02AB04

ATC

methylprednisolone; systemic

1.7

24.5

560

3481

C03CA01

ATC

furosemide; systemic

1.5

24.4

998

7174

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

8.8

24.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

24.2

1366

10491

CBN30

NOMESCO Finland

Shortening of canthal ligament

12.0

24.2

M03BX02

ATC

tizanidine; oral

1.4

23.3

2388

20328

J05AB01

ATC

aciclovir; systemic

1.5

23.3

793

5461

G44.2

ICD-10 Finland

Tension-type headache

1.7

23.2

482

2906

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

23.1

1400

10874

205

Kela drug reimbursment

Chronic hypertension

1.5

22.6

991

7212

S18

ICPC

Laceration/cut

1.4

22.3

1505

11900

H02AB07

ATC

prednisone; oral

1.7

22.1

537

3391

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

22.0

549

3488

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

21.9

1946

16113

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

13.8

21.7

N06AA09

ATC

amitriptyline; systemic

1.9

21.7

338

1851

M54.5

ICD-10 Finland

Low back pain

1.4

21.7

1174

8903

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

21.5

846

6008

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

11.9

21.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

21.5

543

3462

J01FF01

ATC

clindamycin; systemic

1.5

21.3

994

7315

35399

ICD-8 Finland

Sciatica

+∞

20.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

20.8

1284

9964

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

20.5

171

716

R03AC02

ATC

salbutamol; inhalant

1.3

20.2

1971

16489

A02BC03

ATC

lansoprazole; oral

1.4

20.1

1045

7843

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

20.0

279

1467

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

3.2

20.0

107

341

A10BJ06

ATC

semaglutide; parenteral

2.8

19.9

131

478

A10BK03

ATC

empagliflozin; oral

2.0

19.9

251

1268

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

19.8

202

932

SPAT1263

SPAT

Sampling

1.4

19.7

1579

12783

M48.0

ICD-10 Finland

Spinal stenosis

1.8

19.7

368

2144

R06.0

ICD-10 Finland

Dyspnoea

1.5

19.6

861

6243

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

19.5

1563

12646

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.2

19.5

182

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

19.3

222

1081

N06AX21

ATC

duloxetine; oral

1.8

19.3

359

2087

G47.3

ICD-10 Finland

Sleep apnoea

1.5

19.1

753

5335

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

26.1

19.1

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

19.0

737

5203

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

19.0

448

2798

N03

ICPC

Pain face

6.5

19.0

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

18.9

366

2154

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

18.8

952

7098

G53.2*D86.8

ICD-10 Finland

Multiple cranial nerve palsies in sarcoidosis

+∞

18.8

R51.81

ICD-10 Finland

Facial pain NOS

3.3

18.6

283

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

18.5

996

7508

ZXA00

NOMESCO Finland

Right side

1.4

18.3

931

6936

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

18.2

311

1760

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

18.2

228

1152

ZXA10

NOMESCO Finland

Bilateral

1.5

18.1

671

4686

CBF99

NOMESCO Finland

Other operation for ectropion

14.4

18.1

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

17.9

248

1302

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

17.8

1005

7637

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

11.9

17.8

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.5

1466

11891

ZXA05

NOMESCO Finland

Left side

1.4

17.4

886

6595

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

17.4

423

2661

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.3

17.4

164

729

A10AE06

ATC

insulin degludec; parenteral

2.9

17.3

108

383

N03AF01

ATC

carbamazepine; oral, rectal

2.2

17.3

179

831

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

17.2

551

3720

M25.5

ICD-10 Finland

Pain in joint

1.4

17.2

977

7423

N06AX16

ATC

venlafaxine; oral

1.6

17.2

478

3119

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.4

17.2

257

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.5

17.1

136

557

M01AE02

ATC

naproxen; oral, rectal

1.3

17.0

2110

18121

M01AB05

ATC

diclofenac; systemic, rectal

1.3

16.8

2569

22706

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

16.8

391

2432

QAJ35

NOMESCO Finland

Other correction of loose or redundant skin of head or neck

+∞

16.7

C10AA01

ATC

simvastatin; oral

1.3

16.6

1509

12372

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.7

16.5

197

SPAT1301

SPAT

No procedures

1.4

16.4

1131

8875

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

16.3

552

3769

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

16.3

2060

17690

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

40.2

16.3

B02.8

ICD-10 Finland

Zoster with other complications

7.8

16.3

M01AH05

ATC

etoricoxib; oral

1.3

16.2

2173

18812

H01

ICPC

Ear pain/earache

1.7

16.2

368

2270

R4120

NOMESCO Finland

Occupational therapy

2.0

16.2

223

1169

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

16.2

164

757

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

16.2

305

1780

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

16.2

252

1381

R06AE07

ATC

cetirizine; oral

1.3

16.1

1602

13294

D33.3

ICD-10 Finland

Benign neoplasm: Cranial nerves

47.7

16.0

A02BC05

ATC

esomeprazole; systemic

1.3

15.8

1459

11966

H66.9

ICD-10 Finland

Otitis media, unspecified

2.0

15.7

198

1002

WX002

NOMESCO Finland

Sedation and analgesia

1.5

15.7

689

4971

E66.8

ICD-10 Finland

Other obesity

2.1

15.7

185

912

ELB50

NOMESCO Finland

Total parotidectomy

11.2

15.7

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

8.3

15.7

A02BC01

ATC

omeprazole; systemic

1.4

15.6

972

7482

G51.1

ICD-10 Finland

Geniculate ganglionitis

+∞

15.6

ZZK00

NOMESCO Finland

Graft of nerve

+∞

15.6

35002

ICD-8 Finland

Facial paralysis, Spasmus facialis

+∞

15.6

SPAT1153

SPAT

Removal of sutures

1.4

15.6

1087

8529

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

15.6

594

4167

S04.5

ICD-10 Finland

Injury of facial nerve

85.4

15.6

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

15.3

212

1116

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

15.2

606

4285

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

15.2

246

1364

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

15.2

1466

12082

DC1AD

NOMESCO Finland

Temporalbone CT

4.3

15.0

129

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

15.0

364

2287

L01

ICPC

Neck symptom/complaint

1.6

15.0

450

2987

B01AC04

ATC

clopidogrel; oral

1.5

14.9

508

3474

AAE32

NOMESCO Finland

Translabyrinthine excision acoustic neurinome

31.8

14.8

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

14.7

188

959

QAJ30

NOMESCO Finland

Other facelift

9.7

14.7

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.5

14.6

114

464

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

14.5

332

UJF32

NOMESCO Finland

Coloscopy

1.4

14.3

874

6695

T89

ICPC

Diabetes insulin dependent

2.3

14.3

133

591

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

14.3

734

5455

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

14.2

207

1107

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

14.2

740

5513

CBB20

NOMESCO Finland

Correction of lax skin of eyelid and resection of herniated fat

3.6

14.1

177

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.1

14.1

247

A10BH05

ATC

linagliptin; oral

2.1

14.0

158

764

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

4.8

14.0

R07.3

ICD-10 Finland

Other chest pain

1.7

13.8

312

1920

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

13.8

230

1290

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.8

537

3779

G35

ICD-10 Finland

Multiple sclerosis

3.1

13.8

240

R4110

NOMESCO Finland

Physiotherapy

1.4

13.7

939

7326

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.4

13.7

111

460

C07AB07

ATC

bisoprolol; oral

1.3

13.6

1644

13920

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

13.6

1083

8652

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

13.5

114

483

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

14.7

13.5

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

+∞

13.5

P01AB01

ATC

metronidazole; oral, rectal

1.3

13.5

1408

11682

L03

ICPC

Low back symptom/complaint

1.4

13.5

772

5842

K02.1

ICD-10 Finland

Caries of dentine

1.3

13.5

2101

18365

EBA00

NOMESCO Finland

Extraction of tooth

1.3

13.4

1151

9290

J01MA02

ATC

ciprofloxacin; systemic

1.3

13.4

1382

11447

160

Kela drug reimbursment

exenatide

2.9

13.4

279

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

13.4

239

1372

2251A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cranial nerves

25.8

13.3

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

13.3

354

2279

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

13.2

947

7436

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

13.2

699

5221

J01FA06

ATC

roxithromycin; oral

1.3

13.1

1450

12114

CBW99

NOMESCO Finland

Other operation on eyelid

40.2

13.1

H92.0

ICD-10 Finland

Otalgia

2.0

13.1

165

836

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

13.1

206

1136

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.8

13.1

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

13.1

568

4081

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

13.1

1930

16736

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

13.1

1748

14975

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

4.1

13.0

124

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.6

12.9

A02BA02

ATC

ranitidine; systemic

1.4

12.8

668

4973

M01AC06

ATC

meloxicam; systemic, rectal

1.3

12.8

1271

10467

N03AE01

ATC

clonazepam; systemic

1.9

12.8

191

1034

L12

ICPC

Hand/finger symptom/complaint

1.5

12.8

439

3007

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.2

12.7

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.3

12.5

116

516

N02AA05

ATC

oxycodone; systemic

1.5

12.5

466

3243

R52.9

ICD-10 Finland

Pain, unspecified

1.7

12.5

271

1652

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

12.5

537

3854

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

12.5

515

3667

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

130.3

12.4

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

12.3

904

7118

C10AA05

ATC

atorvastatin; oral

1.3

12.3

1284

10629

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

12.2

253

1521

N05CF01

ATC

zopiclone; oral

1.3

12.2

1119

9101

DEB30

NOMESCO Finland

Radical mastoidectomy

12.4

12.1

TQA05

NOMESCO Finland

Puncture of skin of head or neck

21.3

12.0

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

11.9

2659

24109

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

11.9

980

7842

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.0

11.8

116

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.4

11.7

168

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

11.7

366

A46

ICD-10 Finland

Erysipelas

1.5

11.7

454

3189

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.4

11.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

11.7

1351

11321

QAJ15

NOMESCO Finland

Browlift using video-endoscope

16.4

11.6

C09AA02

ATC

enalapril; systemic

1.4

11.6

643

4830

G51.4

ICD-10 Finland

Facial myokymia

22.9

11.6

L86

ICPC

Back syndrome with radiating pain

1.9

11.5

173

941

G51.2

ICD-10 Finland

Melkersson syndrome

+∞

11.5

ELB60

NOMESCO Finland

Radical parotidectomy sacrificing the facial nerve

+∞

11.5

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

11.5

135

669

A10AB06

ATC

insulin glulisine; parenteral

4.0

11.4

110

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

11.4

918

7315

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

11.3

324

2122

G61.0

ICD-10 Finland

Guillain-Barré syndrome

7.8

11.3

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

11.2

3656

34586

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

11.2

612

4584

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

11.2

2658

24179

J01FA09

ATC

clarithromycin; systemic

1.3

11.2

1101

9017

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

11.2

351

2353

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

11.2

650

4923

L17

ICPC

Foot/toe symptom/complaint

1.3

11.1

812

6374

109

Kela drug reimbursment

Multiple sclerosis

3.4

11.1

159

A10BJ02

ATC

liraglutide; parenteral

2.6

11.1

318

C09CA01

ATC

losartan; oral

1.3

11.1

793

6208

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

11.0

165

893

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

11.0

268

1686

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.0

1459

12408

G50.9

ICD-10 Finland

Disorder of trigeminal nerve, unspecified

43.4

10.9

R50.9

ICD-10 Finland

Fever, unspecified

1.4

10.9

465

3329

A10BX04

ATC

[U] exenatide; parenteral

3.5

10.8

141

L28

ICPC

Limited function/disability (L)

1.4

10.8

476

3428

H16.0

ICD-10 Finland

Corneal ulcer

1.9

10.8

155

828

A10BB01

ATC

glibenclamide; oral

2.0

10.8

130

651

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

10.8

806

6352

R05

ICPC

Cough

1.3

10.7

727

5641

M54.2

ICD-10 Finland

Cervicalgia

1.7

10.7

215

1282

CBC10

NOMESCO Finland

Removal of foreign body from eyelid

21.5

10.7

AAE34

NOMESCO Finland

Other operations on acoustical nerv

60.1

10.6

CBH10

NOMESCO Finland

Plactic repair of canthus

60.1

10.6

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

10.6

893

7158

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

10.6

159

864

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.5

1092

9000

M02AA07

ATC

piroxicam; topical

1.3

10.5

1238

10365

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

10.4

499

3646

A10BJ01

ATC

exenatide; parenteral

3.8

10.4

110

G52.9

ICD-10 Finland

Cranial nerve disorder, unspecified

110.3

10.4

G52.7

ICD-10 Finland

Disorders of multiple cranial nerves

+∞

10.4

N06AB04

ATC

citalopram; systemic

1.3

10.4

733

5717

R51

ICD-10 Finland

Headache

1.8

10.4

167

929

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

10.4

827

6573

C09AA05

ATC

ramipril; oral

1.3

10.3

816

6472

C08CA13

ATC

lercanidipine; oral

1.5

10.3

405

2852

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

10.3

335

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

10.3

948

7687

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

10.3

1143

9499

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

18.8

10.2

R01AD09

ATC

mometasone; nasal

1.2

10.2

1583

13680

WX290

NOMESCO Finland

Other blockade of nerve

1.2

10.2

1546

13324

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

10.2

538

4004

R52.2

ICD-10 Finland

Other chronic pain

2.2

10.2

100

460

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

10.2

290

1899

M79.1

ICD-10 Finland

Myalgia

1.5

10.2

396

2781

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

7.5

10.2

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

13.1

10.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

10.1

694

5387

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

2.6

10.1

270

J01MA12

ATC

levofloxacin; systemic

1.4

10.1

609

4635

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.6

10.1

289

M54.3

ICD-10 Finland

Sciatica

1.8

10.0

176

1010

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.6

10.0

119

S29

ICPC

Skin symptom/complaint other

1.4

10.0

538

4013

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.0

1414

12082

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

10.0

343

2345

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

10.0

260

1665

XCK00

NOMESCO Finland

Perimetry

1.7

9.9

221

1357

A10BG03

ATC

pioglitazone; oral

2.3

9.9

392

XA402

NOMESCO Finland

ENMG

2.7

9.8

232

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

9.8

438

3160

J01CA04

ATC

amoxicillin; systemic

1.2

9.8

3173

29628

B02.29

ICD-10 Finland

Herpes zoster polyneuropathy

26.1

9.8

CBH40

NOMESCO Finland

Division of tarsorrhaphy

26.1

9.8

EAB20

NOMESCO Finland

Plastic repair of lip

26.1

9.8

H60.3

ICD-10 Finland

Other infective otitis externa

2.4

9.8

344

132

Kela drug reimbursment

Sarcoidosis

4.0

9.8

N18

ICPC

Paralysis/weakness

2.6

9.8

257

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

9.7

273

1785

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

9.7

330

2256

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

9.6

982

8061

CBK10

NOMESCO Finland

Operation for lagophtalmus

55.1

9.6

N06AX11

ATC

mirtazapine; oral

1.3

9.6

1077

8945

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.6

1071

8887

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.0

9.6

125

646

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.6

394

2798

SPAT1260

SPAT

Consultation of another employee

1.4

9.5

578

4399

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.7

9.5

231

M04AA01

ATC

allopurinol; systemic

1.4

9.5

392

2786

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.5

9.5

280

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

9.5

275

1810

CBD99

NOMESCO Finland

Other plastic reconstruction of eyelid

9.1

9.5

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.4

9.4

312

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

9.4

175

QAZ00

NOMESCO Finland

Botulin injections for hyperhidrosis of head and neck

100.2

9.4

DEB00

NOMESCO Finland

Cortical mastoidectomy

30.1

9.4

3518X

ICD-9 Finland

Facial nerve disorders, Other facial nerve disorders

+∞

9.4

3542A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Lesion of ulnar nerve

+∞

9.4

35701

ICD-8 Finland

Other diseases of peripheral nerves except autonomic, Nervi mediani

+∞

9.4

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

9.4

440

3205

N07CA01

ATC

betahistine; oral

1.6

9.4

238

1518

G24.5

ICD-10 Finland

Blepharospasm

8.0

9.3

R03BA02

ATC

budesonide; inhalant

1.4

9.3

567

4322

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

3.7

9.3

107

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

9.3

116

590

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

9.2

204

1253

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

2.3

9.2

349

H46

ICD-10 Finland

Optic neuritis

3.7

9.2

103

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.9

9.2

128

680

M65.3

ICD-10 Finland

Trigger finger

2.0

9.2

105

519

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.3

9.1

363

J01FA10

ATC

azithromycin; systemic

1.2

9.1

2112

18969

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

9.1

620

4808

J01MA14

ATC

moxifloxacin; systemic

1.5

9.0

276

1842

A10AA02

ATC

2.1

9.0

456

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.7

9.0

221

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

9.0

338

2358

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

9.0

374

2662

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

9.0

262

1730

SPAT1216

SPAT

Assessment of functional ability

1.4

9.0

473

3514

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

9.0

441

3241

J01DA06

ATC

[U] cefuroxime; systemic

1.4

8.9

483

3608

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

8.9

684

5393

G56.4

ICD-10 Finland

Causalgia

18.6

8.9

R05FB02

ATC

cough suppressants and expectorants

1.2

8.9

1295

11073

H93.1

ICD-10 Finland

Tinnitus

1.6

8.9

203

1260

CBK99

NOMESCO Finland

Other operation for retraction of eyelid

24.0

8.9

C10AX09

ATC

ezetimibe; oral

1.5

8.9

329

2287

H57.1

ICD-10 Finland

Ocular pain

2.1

8.8

100

491

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.7

8.8

212

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

8.8

390

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

10.7

8.8

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

8.7

138

764

A10AA01

ATC

2.3

8.7

339

J02AC01

ATC

fluconazole; systemic

1.2

8.7

1367

11777

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.9

8.7

178

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

3.9

8.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

8.7

1133

9564

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

8.7

116

608

H51.0

ICD-10 Finland

Palsy of conjugate gaze

50.1

8.7

C09BA02

ATC

enalapril and diuretics; systemic

1.5

8.6

255

1689

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

8.6

173

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

8.6

347

2454

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.6

8.6

227

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

8.6

285

1939

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

8.6

251

1661

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.1

8.5

148

9560/0-C72.5

ICD-O-3

Schwannoma, NOS, of cranial nerve, NOS

27.5

8.5

E85.80

ICD-10 Finland

Meretoja sick

20.0

8.5

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

8.5

185

1134

Z71.8

ICD-10 Finland

Other specified counselling

1.3

8.5

792

6416

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

8.4

145

829

Q51.0

ICD-10 Finland

Agenesis and aplasia of uterus

90.2

8.4

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

8.4

212

1349

N01

ICPC

Headache

1.5

8.4

293

2012

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

8.4

389

2830

T82

ICPC

Obesity

1.9

8.4

116

618

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

8.4

334

2362

R13

ICD-10 Finland

Dysphagia

1.6

8.4

191

1188

R01AD08

ATC

fluticasone; nasal

1.3

8.3

953

7917

3519X

ICD-9 Finland

Facial nerve disorders, Facial nerve disorder, unspecified

+∞

8.3

4182

FHL

Surgery on the facial nerve

+∞

8.3

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.3

8.3

123

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

10.7

8.3

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.4

8.2

264

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

8.2

900

7435

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

8.2

122

662

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.7

8.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

8.2

458

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

8.2

425

3153

J20

ICD-10 Finland

Acute bronchitis

1.5

8.2

295

2042

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

8.2

110

579

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

8.2

164

984

R52.1

ICD-10 Finland

Chronic intractable pain

4.2

8.2

G03.9

ICD-10 Finland

Meningitis, unspecified

6.5

8.2

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

8.2

136

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

8.1

169

1024

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

8.1

182

1124

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.1

698

5587

L08

ICPC

Shoulder symptom/complaint

1.3

8.1

558

4327

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

5.4

8.1

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.4

8.1

K07.60

ICD-10 Finland

Snapping jaw

1.8

8.1

142

816

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

8.1

394

2891

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

33.4

8.1

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

8.1

235

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

8.0

123

678

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

8.0

555

4312

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.0

653

5192

R03DC03

ATC

montelukast; oral

1.3

8.0

498

3806

J01EA01

ATC

trimethoprim; systemic

1.3

8.0

830

6810

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

7.9

142

821

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.5

7.9

239

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

7.9

311

2195

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

7.9

607

4787

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

7.9

371

2707

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

7.8

134

766

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

7.8

124

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

7.8

377

A06AD11

ATC

lactulose; oral

1.4

7.8

424

3171

M03BX01

ATC

baclofen; systemic

2.6

7.8

210

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.7

7.8

193

G04CA02

ATC

tamsulosin; oral

1.3

7.8

666

5329

CBF20

NOMESCO Finland

Resection of part of tarsus for ectropion

9.4

7.8

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

7.8

191

1211

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

7.8

165

1007

F29

ICPC

Eye symptom/complaint other

1.5

7.8

249

1681

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

7.7

392

R74

ICPC

Upper respiratory infection acute

1.3

7.7

906

7543

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

45.0

7.7

R11

ICD-10 Finland

Nausea and vomiting

1.5

7.7

235

1568

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

7.7

395

2922

Z50.1

ICD-10 Finland

Other physical therapy

1.7

7.7

156

940

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

7.7

340

2451

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.8

7.7

165

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

7.7

129

734

C03AA03

ATC

hydrochlorothiazide; oral

1.5

7.7

291

2035

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.7

227

1506

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

7.7

549

4285

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.6

856

7087

G53.0

ICD-10 Finland

Postzoster neuralgia

4.7

7.6

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

7.6

225

1494

S06.0

ICD-10 Finland

Concussion

1.4

7.6

310

2203

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

7.6

235

1577

R01AD11

ATC

triamcinolone; nasal

1.5

7.6

270

1867

Z01.2

ICD-10 Finland

Dental examination

1.2

7.5

1395

12188

E0000UV

ATC

1.2

7.5

1358

11833

H70.0

ICD-10 Finland

Acute mastoiditis

8.8

7.5

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

7.5

608

4827

R60.0

ICD-10 Finland

Localized oedema

1.4

7.5

333

2403

R03BA05

ATC

fluticasone; inhalant

1.3

7.5

579

4568

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

7.4

2340

21465

A10BK01

ATC

dapagliflozin; oral

1.7

7.4

132

764

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

4.5

7.4

A10BX07

ATC

[U] liraglutide; parenteral

2.8

7.4

158

L15

ICPC

Knee symptom/complaint

1.3

7.3

629

5034

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

7.3

741

6058

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

7.3

542

4250

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.8

7.3

111

613

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

7.3

192

1238

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

7.3

384

N02AC04

ATC

dextropropoxyphene; oral

1.8

7.3

107

585

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

7.3

155

948

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

7.2

279

1961

L03AB07

ATC

interferon beta-1a; parenteral

3.9

7.2

H01.0

ICD-10 Finland

Blepharitis

1.6

7.2

163

1011

M75.8

ICD-10 Finland

Other shoulder lesions

1.9

7.2

100

531

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

7.2

106

576

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.2

726

5927

C07AG02

ATC

carvedilol; oral

1.6

7.2

174

1100

SPAT1255

SPAT

Intravenous administration of medicine

1.6

7.2

199

1300

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.2

428

3249

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

7.2

1369

11981

ZX120

NOMESCO Finland

Intravenous

1.4

7.2

299

2134

G56.3

ICD-10 Finland

Lesion of radial nerve

7.3

7.2

A02BA04

ATC

nizatidine; systemic

1.5

7.2

239

1627

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

7.2

217

1449

H19.8*E85.80

ICD-10 Finland

Reticular keratitis in Meretoja's patients

30.0

7.1

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.2

7.1

320

G53.0*B02.21

ICD-10 Finland

Postherpetic geniculate ganglionitis

20.0

7.1

H71

ICD-10 Finland

Cholesteatoma of middle ear

2.8

7.1

150

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

7.1

184

1185

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

7.1

254

1758

B02.20

ICD-10 Finland

Herpes zoster trigeminal neuralgia

12.0

7.1

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.9

7.1

134

A04

ICPC

Weakness/tiredness general

1.4

7.0

392

2945

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.2

7.0

283

A01

ICPC

Pain general/multiple sites

1.5

7.0

206

1368

TDA90

NOMESCO Finland

Removal wax from ear

2.6

7.0

182

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.4

7.0

237

F03

ICPC

Eye discharge

1.6

6.9

181

1167

A03

ICPC

Fever

1.3

6.9

473

3666

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

6.9

681

5548

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

2.8

6.9

147

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

7.5

6.9

A10BG02

ATC

rosiglitazone; oral

2.5

6.9

195

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.8

6.9

120

691

SPAT1312

SPAT

General health counselling

1.2

6.9

1071

9183

N03AF02

ATC

oxcarbazepine; oral

1.9

6.9

463

H65.0

ICD-10 Finland

Acute serous otitis media

2.6

6.9

187

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.9

6.9

131

C02AC05

ATC

moxonidine; oral

1.7

6.8

134

800

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

6.8

924

7801

ZZF00

NOMESCO Finland

Graft of adipose tissue

3.1

6.8

109

C10AA04

ATC

fluvastatin; oral

1.5

6.8

248

1723

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

6.8

538

G56.9

ICD-10 Finland

Mononeuropathy of upper limb, unspecified

8.3

6.8

H62.1

ICD-10 Finland

Otitis externa in viral diseases classified elsewhere

40.1

6.8

8500/3-C07.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of parotid gland

40.1

6.8

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.6

6.7

174

UKC02

NOMESCO Finland

Cystoscopy

1.3

6.7

486

3800

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.3

6.7

248

Z00.0

ICD-10 Finland

General medical examination

1.3

6.7

573

4581

H3600, E103

ICD-10 Finland

3.2

6.7

105

N06AB06

ATC

sertraline; oral

1.4

6.7

325

2385

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

4.7

6.7

D07AC01

ATC

betamethasone; topical

1.2

6.7

1143

9886

ICD-10 Finland

2.1

6.6

315

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.6

312

2278

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

6.6

283

5AB01

NOMESCO Finland

6.4

6.6

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

6.6

527

R75

ICPC

Sinusitis acute/chronic

1.7

6.6

132

794

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

6.6

650

5291

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

3.1

6.6

112

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

5.9

6.6

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.4

6.6

330

2437

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

6.6

164

1045

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

6.5

611

4942

S01BC03

ATC

diclofenac; ophthalmic

2.0

6.5

422

SPAT1211

SPAT

Application of soft bandage

1.4

6.5

272

1942

A10BH02

ATC

vildagliptin; oral

2.2

6.5

278

SPAT1097

SPAT

Recording of ECG

1.3

6.5

446

3459

K04.0

ICD-10 Finland

Pulpitis

1.4

6.5

288

2078

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

6.5

232

1605

B01AB05

ATC

enoxaparin; parenteral

1.2

6.5

979

8362

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

6.5

387

2937

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

6.5

391

2976

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

6.5

197

1320

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

6.5

232

1609

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.4

758

6304

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

69.9

6.4

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

6.4

390

H62.1*B02.8

ICD-10 Finland

Otitis externa in zoster

14.3

6.4

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

6.4

654

5347

M01AC01

ATC

piroxicam; systemic, rectal

1.3

6.4

420

3238

W19

ICD-10 Finland

Unspecified fall

1.4

6.4

270

1934

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

6.3

267

1909

K08.80

ICD-10 Finland

Toothache NOS

1.5

6.3

229

1589

C01DA14

ATC

isosorbide mononitrate; oral

1.3

6.3

437

3394

SPAT1254

SPAT

Administration of medicine

1.3

6.3

443

3447

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

6.3

134

820

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.1

6.3

E000001

ATC

1.3

6.3

655

5364

SPAT1229

SPAT

Assessment of need for aid

1.5

6.3

217

1491

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

2.8

6.3

132

N05BA01

ATC

diazepam; systemic, rectal

1.3

6.3

406

3118

R02

ICPC

Shortness of breath/dyspnoea

1.4

6.3

348

2608

D33.37

ICD-10 Finland

Another benign tumor of the cranial nerves

11.0

6.3

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

3.5

6.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

6.3

252

1785

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

6.3

202

1370

N92

ICPC

Trigeminal neuralgia

18.0

6.3

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.7

6.3

EKC99

NOMESCO Finland

Other reconstructive operations on cheek

+∞

6.2

A10BD15

ATC

metformin and dapagliflozin; systemic

3.3

6.2

R4130

NOMESCO Finland

Speech therapy

2.1

6.2

327

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

6.2

486

3841

N17

ICPC

Vertigo/dizziness

1.4

6.2

322

2392

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.3

6.2

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

6.2

310

2288

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

6.2

194

1308

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

4.1

6.2

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.7

6.2

150

A10BX02

ATC

repaglinide; oral

2.7

6.2

141

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

3.1

6.2

101

N03AX11

ATC

topiramate; oral

2.0

6.1

370

H29

ICPC

Ear symptom/complaint other

1.4

6.1

294

2153

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

6.1

101

576

C03DA01

ATC

spironolactone; oral

1.4

6.1

311

2300

R21

ICPC

Throat symptom/complaint

1.3

6.1

594

4826

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

6.1

354

2676

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

6.1

363

2757

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.2

6.1

267

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

6.0

180

1198

N06AX12

ATC

bupropion; oral

1.5

6.0

177

1175

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

6.0

186

1249

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.5

6.0

174

1152

N04BC05

ATC

pramipexole; oral

1.5

6.0

199

1355

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

4.4

6.0

A10AD04

ATC

insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.4

6.0

A10BJ05

ATC

dulaglutide; parenteral

3.0

6.0

103

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1205

2545

5.92

307.65

2.5

2.3

au/ml

24.9

23.3

0.12

164

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1119

2317

5.93

307.65

1.4

1.3

au/ml

51.1

44.8

0.28

107

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

221

325

7.07

143.40

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

339

807

4.43

130.04

1.4

1.2

mmol/l

3.8

3.7

0.45

321

756

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

360

926

4.11

124.59

1.5

1.3

mg/l

567.7

511.5

1.03

347

870

(3044290) Cell count panel - Cerebral spinal fluid

310

751

4.33

116.07

1.5

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

314

811

4.06

107.82

1.5

1.4

e6/l

35.7

22.2

0.38

241

607

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

314

812

4.06

107.64

1.6

1.4

e6/l

457.4

1149.6

0.83

252

652

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

123

133

9.46

102.96

1.1

ng/l

882.0

273.4

0.65

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

131

201

6.67

81.51

1.1

u/l

1.1

0.18

103

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1764

11552

1.81

80.97

2.2

2.1

u/l

220.4

218.3

0.03

1673

10831

(3016018) Differential panel - Cerebral spinal fluid

184

392

4.83

80.65

1.4

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3013

23102

1.76

79.40

5.2

4.6

mmol/l

7.0

6.6

12.60

2838

21497

(3023410) Appearance of Cerebral spinal fluid

169

369

4.71

71.89

1.7

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1037

6039

1.90

67.23

2.2

2.1

29.4

29.9

2.38

1013

5855

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

191

6.14

66.21

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

138

277

5.09

64.84

1.1

mg/l

344.1

260.7

1.27

117

243

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

140

287

4.99

64.19

1.2

1.1

mg/l

47.8

40.3

0.67

117

237

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

202

5.65

59.23

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

6.60

55.21

1.1

—

(3032080) INR in Blood by Coagulation assay

2104

15582

1.60

55.08

8.5

9.1

inr

1.2

1.3

3.06

636

4541

(4027681)

110

211

5.31

54.41

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

121

266

4.64

51.05

1.1

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

126

291

4.42

49.99

1.2

1.3

mmol/l

2.0

0.21

121

268

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1962

14551

1.57

49.44

3.9

3.4

ng/l

37.5

49.3

1.32

1348

9680

(3020682) Albumin/Creatinine [Ratio] in Urine

1639

11699

1.60

48.44

4.4

3.9

mg/mmol

9.7

9.5

0.04

1094

7415

(3012516) Albumin [Mass/volume] in Urine

1570

11114

1.60

47.94

3.5

3.2

mg/l

525.9

318.4

0.84

1058

7019

(3009508) Creatinine [Moles/volume] in Urine

1664

11983

1.58

47.04

3.4

3.1

mmol/l

7.7

7.6

0.06

1393

10093

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2451

19371

1.52

44.70

7.5

6.6

mmol/l

1.2

0.50

2067

16293

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2539

20340

1.50

42.57

6.4

6.3

umol/l

11.0

11.5

1.43

2437

19271

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

129

343

3.83

42.37

1.3

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

185

4.99

42.17

1.3

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4445

40648

1.84

39.62

17.6

13.4

mg/l

21.9

23.9

4.14

3754

31890

(3023368) Bacteria identified in Blood by Culture

1450

10451

1.55

39.28

4.6

4.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

142

5.42

38.74

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2224

17564

1.48

38.59

6.7

5.9

mmol/l

1.2

0.02

2031

15866

(3024561) Albumin [Mass/volume] in Serum or Plasma

2148

16851

1.48

38.53

5.0

4.8

g/l

35.6

35.5

0.29

1983

15636

(3013707) Erythrocyte sedimentation rate by Westergren method

3422

29461

1.51

38.28

4.6

3.8

mm/h

12.5

12.0

1.44

3223

27224

(3019550) Sodium [Moles/volume] in Serum or Plasma

4523

41674

1.89

38.08

19.8

15.3

mmol/l

139.6

139.7

1.32

4439

40557

(3023103) Potassium [Moles/volume] in Serum or Plasma

4533

41811

1.89

37.81

19.9

15.4

mmol/l

4.0

1.57

4442

40616

(3007853) Bacteria identified in Skin by Aerobe culture

722

4466

1.72

36.11

1.8

1.7

—

(3006315) Basophils [#/volume] in Blood

2441

19904

1.44

34.33

6.9

5.8

e9/l

0.0

0.10

2105

17099

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3515

30704

1.49

34.27

8.4

7.4

u/l

78.5

78.1

0.20

3310

28862

(3019198) Lymphocytes [#/volume] in Blood

2491

20412

1.44

33.96

7.0

5.9

e9/l

1.9

0.46

2191

17897

(3001604) Monocytes [#/volume] in Blood

2428

19823

1.44

33.65

6.9

5.8

e9/l

0.6

1.17

2097

17036

(3037467) Urinalysis macro (dipstick) panel - Urine

3204

27573

1.45

33.04

4.9

4.1

—

(3022096) Basophils/100 leukocytes in Blood

2240

18095

1.43

32.49

7.2

6.1

0.7

0.92

2103

16862

(3013650) Neutrophils [#/volume] in Blood by Automated count

2755

23118

1.43

32.21

9.9

9.2

e9/l

4.2

4.1

2.47

2417

20076

(3013115) Eosinophils [#/volume] in Blood

2497

20590

1.42

32.18

7.1

6.0

e9/l

0.2

0.61

2188

17981

(3005719) IgG [Mass/volume] in Serum or Plasma

508

2951

1.80

31.38

2.8

2.7

g/l

9.8

10.6

4.10

464

2690

(3019069) Monocytes/100 leukocytes in Blood

2300

18755

1.42

31.19

7.5

6.3

8.6

0.08

2166

17545

(42870588) Differential panel, method unspecified - Blood

1735

13453

1.44

31.07

7.0

5.9

—

(3006504) Eosinophils/100 leukocytes in Blood

2286

18649

1.42

30.77

7.2

6.0

2.8

2.9

0.59

2146

17352

(3002030) Lymphocytes/100 leukocytes in Blood

2354

19305

1.41

30.74

7.3

6.1

27.3

27.9

1.75

2218

17958

(3031040) Bacteria [#/volume] in Urine by Automated count

3051

26248

1.42

29.87

5.2

4.3

e6/l

607.7

1719.0

1.23

347

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.12

29.67

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1578

12115

1.44

29.43

2.7

2.5

u/l

54.3

58.9

3.61

1456

11157

(3018010) Neutrophils/100 leukocytes in Blood

2314

19025

1.40

29.22

6.9

5.9

58.0

57.3

1.99

2180

17771

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

317

1622

2.02

28.77

2.5

1.9

u/l

40.2

39.4

0.30

294

1439

(3026008) Bacteria identified in Urine by Culture

1522

11650

1.44

28.69

3.4

3.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

5.14

26.12

1.1

1.2

—

(3018418) pH of Serum or Plasma

1490

11523

1.42

25.97

4.4

4.0

7.4

0.11

313

2216

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4033

36870

1.48

25.79

7.0

5.4

mmol/mol

41.7

39.3

29.81

3746

34106

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1950

15839

1.38

25.22

2.1

1.9

pmol/l

95.7

95.4

0.06

1030

8219

(3000850) Epithelial cells [#/volume] in Urine

1121

8268

1.46

25.17

2.8

2.6

e6/l

5.3

5.8

0.63

973

7198

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4043

37085

1.47

24.41

5.2

4.6

mu/l

1.9

2.1

1.95

3739

33972

(3036481) Cortisol [Moles/volume] in Serum or Plasma

549

3499

1.64

23.94

2.4

2.2

nmol/l

350.2

377.3

2.60

508

3212

(3002582) Erythrocytes [#/volume] in Urine

1530

12021

1.39

23.89

3.6

3.2

e6/l

156.1

96.0

0.33

1176

9124

(3033658) Prothrombin time (PT) actual/Normal

1337

10315

1.40

23.09

4.3

3.9

92.2

90.1

2.48

1312

10067

(3030467) Casts [#/volume] in Urine by Automated count

1416

11061

1.39

22.64

3.4

3.1

e6/l

0.4

0.13

1062

8237

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

869

6225

1.48

22.35

1.9

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1013

7476

1.45

22.31

3.9

3.6

ng/l

528.6

556.1

0.05

738

5758

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.28

21.98

1.1

—

(3026782) Osmolality of Urine

1042

7760

1.43

21.78

3.0

2.7

mosm/kgh2o

537.7

547.0

0.62

891

6580

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2070

17271

1.34

21.37

3.1

2.8

ug/l

115.8

128.0

1.78

1886

15994

(3042936) Bacteria identified in Isolate by Culture

766

5411

1.49

21.01

2.1

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1267

9821

1.39

20.91

2.4

2.2

mg/l

3.1

2.9

1.30

1076

8384

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4145

38484

1.45

20.88

15.8

12.6

ml/min/173m2

82.0

81.8

0.17

3486

31703

(3018095) Leukocytes [#/volume] in Urine

1732

14121

1.35

20.70

4.2

3.6

e6/l

121.6

95.3

0.37

1248

9844

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3436

30966

1.35

20.40

4.4

3.9

pmol/l

14.7

14.8

0.03

3155

28148

(40761511) CBC panel - Blood by Automated count

4505

42599

1.58

20.19

16.6

12.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1606

12996

1.35

20.01

3.6

3.2

u/l

32.3

36.6

1.68

1515

12326

(3021589) Normoblasts [#/volume] in Blood

2135

18009

1.32

19.99

10.9

9.3

e9/l

0.0

0.26

1770

14651

(3009261) Glucose [Presence] in Urine by Test strip

2317

19778

1.32

19.90

4.2

3.5

estimate

0.0

0.18

452

3619

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

237

3.24

19.76

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1310

10295

1.37

19.65

2.8

2.6

umol/l

3714.4

4866.7

0.45

1152

8967

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4577

43501

1.61

19.35

12.2

9.9

u/l

28.5

26.4

2.76

4426

41885

(36304419) Bacteria [Presence] in Urine

1359

10768

1.36

19.28

3.4

3.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

2287

19550

1.31

19.17

5.5

4.7

estimate

0.0

0.34

462

3716

(3035350) Ketones [Presence] in Urine by Test strip

2280

19495

1.31

19.02

4.1

3.5

estimate

0.0

1.08

465

3647

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2195

18682

1.31

18.90

4.4

4.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

219

3.27

18.80

1.1

nmol/l

4.4

11.7

0.47

(3003458) Phosphate [Moles/volume] in Serum or Plasma

704

5007

1.47

18.50

6.5

5.8

mmol/l

1.1

1.0

0.74

647

4665

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

615

4271

1.50

18.17

1.9

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.17

18.13

1.1

1.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1345

10735

1.35

17.96

3.2

3.0

ng/l

1447.7

1426.0

0.06

1125

9157

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

181

3.46

17.92

1.3

46.2

65.9

—

(3037522) Nuclear Ab [Titer] in Serum

720

5180

1.46

17.78

1.4

1.3

titre

478.9

543.3

0.48

151

1076

(3022948) Iron [Moles/volume] in Serum or Plasma

817

6041

1.42

17.35

2.7

2.4

umol/l

12.8

13.2

0.86

751

5625

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1111

8667

1.36

17.08

2.0

1.7

mg/l

1.3

1.2

0.19

846

6578

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

716

5187

1.44

16.99

2.7

2.5

22.0

23.1

1.14

593

4478

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

608

4268

1.48

16.98

1.8

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1054

8161

1.37

16.98

1.8

1.6

pmol/l

78366394.1

33762250.0

0.62

869

6768

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

5.91

16.96

1.2

78.4

58.4

1.33

(3019309) Folate [Moles/volume] in Red Blood Cells

926

7024

1.39

16.92

1.8

1.7

nmol/l

1161.4

1171.0

0.11

721

5292

(3007461) Platelets [#/volume] in Blood

4738

45604

1.73

16.86

25.6

19.8

e9/l

252.2

251.3

0.42

4631

44412

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3023

27080

1.29

16.78

3.5

3.0

u/l

49.9

47.6

0.86

2841

25221

(3024731) MCV [Entitic volume]

4739

45627

1.73

16.70

25.5

19.7

90.6

91.0

6.50

4688

44961

(3035941) MCH [Entitic mass]

4739

45628

1.73

16.69

25.5

19.7

30.2

30.3

6.81

4689

44959

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

102

4.24

16.65

1.2

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

4739

45635

1.73

16.58

25.6

19.8

e12/l

4.5

0.46

4630

44314

(3004789) Transferrin [Mass/volume] in Serum or Plasma

757

5566

1.42

16.53

2.7

2.4

g/l

2.4

2.3

1.70

694

5175

(3010813) Leukocytes [#/volume] in Blood

4739

45644

1.72

16.45

25.6

19.8

e9/l

7.0

6.7

8.15

4627

44310

(3000963) Hemoglobin [Mass/volume] in Blood

4739

45645

1.72

16.43

25.8

19.9

g/l

135.2

135.6

1.07

4691

44979

(3044640) Blood type and Crossmatch panel - Blood

1546

12744

1.31

16.10

2.6

2.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

101

4.19

15.99

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

4.03

15.91

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1116

8813

1.34

15.65

1.6

1.5

nmol/l

19.6

20.5

1.16

948

7548

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.03

15.57

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

190

1010

1.92

15.49

2.4

2.0

mg/l

10.2

11.4

0.92

175

937

(3012095) Magnesium [Moles/volume] in Serum or Plasma

834

6324

1.38

15.11

3.5

3.4

mmol/l

0.8

0.25

781

5918

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

110

3.93

15.09

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

511

3549

1.49

14.98

4.4

3.7

kpa

5.8

0.03

494

3442

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4159

39149

1.37

14.96

5.0

4.3

mmol/l

6.1

5.9

20.14

3809

35688

(3012544) pH of Venous blood

527

3685

1.48

14.94

4.4

3.7

—

7.4

—

(3002032) Base excess in Venous blood by calculation

509

3541

1.49

14.79

4.4

3.8

mmol/l

1.8

1.9

0.30

416

2875

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

415

2769

1.54

14.70

1.8

1.7

—

(3003396) Base excess in Arterial blood by calculation

597

4289

1.45

14.70

7.5

7.6

mmol/l

0.9

1.0

0.27

448

3346

(3017181) Myelocytes/100 leukocytes in Blood

478

3288

1.50

14.68

4.0

4.3

1.0

0.9

0.08

136

923

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

118

539

2.22

14.51

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1777

15069

1.28

14.50

4.4

3.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

6.60

14.46

1.1

5.9

20.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1901

16275

1.27

14.29

2.4

2.2

nmol/l

75.3

77.3

2.54

1726

14655

(3027801) Oxygen [Partial pressure] in Arterial blood

596

4308

1.44

14.17

7.6

kpa

12.0

12.5

1.60

570

4102

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

596

4308

1.44

14.17

7.6

kpa

5.0

5.1

0.36

570

4097

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

909

7069

1.35

13.92

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

454

3129

1.50

13.80

4.0

4.3

0.1

0.2

0.84

128

852

(3028679) Herpes simplex virus Ab [Presence] in Serum

192

3.04

13.76

1.1

—

(3013512) EKG study

1366

11281

1.29

13.54

4.4

3.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

872

6768

1.35

13.49

3.0

2.7

e6/l

1.0

1.2

0.79

486

3782

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

101

3.88

13.48

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

437

3010

1.50

13.31

3.6

4.1

0.6

0.04

669

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

833

6433

1.35

13.30

1.3

iu/ml

32.6

32.3

0.02

286

1976

(3024354) Oxygen [Partial pressure] in Venous blood

426

2924

1.50

13.20

3.9

3.1

kpa

4.6

0.02

409

2825

(3020630) Protein [Mass/volume] in Serum or Plasma

447

3109

1.48

12.97

2.6

g/l

66.3

66.5

0.17

408

2845

(3025159) Blasts/100 leukocytes in Blood

428

2955

1.49

12.88

4.1

4.3

0.0

0.2

0.63

103

715

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.04

12.80

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1574

13303

1.27

12.80

3.2

3.4

mmol/l

2.4

0.18

1360

11613

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

463

3259

1.46

12.64

2.3

ug/l

7.6

7.9

0.07

399

2853

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

430

2.26

12.43

1.5

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

258

1602

1.64

12.39

1.5

u/ml

31.5

15.5

—

(3044889) 12 lead EKG panel

3070

28054

1.24

12.16

4.0

3.6

—

(3002385) Erythrocyte distribution width [Ratio]

3642

33972

1.26

11.83

20.6

16.4

13.8

13.7

2.72

3577

33194

(3027273) Bicarbonate [Moles/volume] in Venous blood

276

1763

1.60

11.83

3.6

3.3

mmol/l

25.3

25.2

0.22

266

1707

(3016502) Oxygen saturation in Arterial blood

525

3828

1.42

11.82

8.1

95.6

95.7

0.14

509

3679

(3019150) Specific gravity of Urine by Refractometry

1026

8288

1.30

11.81

4.6

3.9

kg/l

1.0

0.47

150

1222

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

300

2.45

11.51

2.4

2.2

10.6

13.6

1.24

133

(3011412) CD3 cells [#/volume] in Blood

382

2.27

11.40

2.7

2.5

e9/l

1.3

1.2

0.44

237

(3029937) Albumin [Presence] in Urine by Test strip

1252

10440

1.27

11.09

4.7

3.9

estimate

0.0

1.54

451

3554

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

806

6356

1.32

10.99

3.3

2.9

e6/l

3.6

2.6

1.19

418

3393

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1174

9733

1.27

10.88

2.4

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4277

40844

1.32

10.78

5.3

4.7

mmol/l

2.7

2.8

5.29

3953

37654

(3002173) Hemoglobin [Mass/volume] in Arterial blood

483

3535

1.41

10.63

8.4

8.5

g/l

120.9

121.4

0.21

471

3400

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

288

2.42

10.56

2.3

2.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

342

2351

1.49

10.52

4.1

3.6

kpa

5.1

5.2

0.17

313

2176

(3004588) Protein electrophoresis panel - Serum or Plasma

365

2544

1.47

10.47

2.5

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1271

10679

1.25

10.45

3.8

3.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

158

900

1.78

10.45

3.8

3.2

mmol/l

24.6

24.9

0.48

145

785

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

766

6051

1.31

10.27

1.3

1.2

u/ml

10.3

12.4

0.35

287

2386

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

328

2247

1.49

10.26

4.1

3.5

mmol/l

1.7

1.8

0.13

243

1665

(40760892) CBC W Ordered Manual Differential panel - Blood

1076

8885

1.27

10.23

5.1

4.4

—

(3009343) pH of Capillary blood

337

2324

1.48

10.21

4.1

3.6

7.4

0.83

275

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4205

40124

1.30

10.20

4.8

4.2

mmol/l

4.6

4.7

9.25

3913

37202

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

499

3699

1.39

10.18

2.4

2.3

g/l

0.2

1.30

464

3443

(3014148) Varicella zoster virus Ab [Titer] in Serum

100

500

2.02

9.86

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

1889

16635

1.22

9.86

2.2

2.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

332

2304

1.47

9.75

2.3

1.9

g/l

1.6

1.4

0.56

310

2102

(3020779) Urea [Moles/volume] in Serum or Plasma

474

3509

1.39

9.74

8.4

7.4

mmol/l

10.0

9.6

0.45

444

3348

(21494815) CD4 cells/100 lymphocytes in Specimen

331

2.25

9.71

2.4

2.3

39.6

41.6

0.11

(3017143) Hepatitis C virus Ab [Presence] in Serum

599

4605

1.34

9.68

1.8

1.6

—

(3000494) Fungus identified in Specimen by Culture

602

4635

1.34

9.63

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

332

2311

1.47

9.60

3.7

3.2

g/l

128.0

129.0

0.35

322

2254

(3014576) Chloride [Moles/volume] in Serum or Plasma

629

4878

1.33

9.58

7.2

mmol/l

104.6

104.5

0.09

613

4776

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

400

2.12

9.45

1.5

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

203

1276

1.62

9.36

1.7

1.6

titre

180.0

383.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

184

1129

1.65

9.34

1.5

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.36

9.32

1.1

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

555

4243

1.35

9.30

2.7

2.6

1.9

1.8

1.88

475

3745

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.89

9.30

3.0

1.8

—

(40768797) Stomach Pathology biopsy report

681

5363

1.31

9.29

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

144

828

1.76

9.27

3.5

3.2

kpa

8.2

0.09

137

765

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

540

4115

1.35

9.24

3.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

120

3.10

9.19

1.1

1.2

23.7

24.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

144

832

1.75

9.12

2.3

2.1

g/l

130.6

128.7

0.36

112

589

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.27

9.11

1.1

—

(40758558) Short blood count panel - Blood

1208

10232

1.24

9.03

7.4

6.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

175

1071

1.66

8.98

1.3

1.4

u/l

11.2

9.9

0.58

137

880

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

137

787

1.76

8.86

3.8

59.1

57.2

1.07

137

787

(3008152) Bicarbonate [Moles/volume] in Arterial blood

326

2298

1.45

8.84

8.9

7.1

mmol/l

24.4

24.5

0.18

303

2132

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4164

39838

1.27

8.83

4.7

4.2

mmol/l

1.4

1.5

28.01

3849

36733

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

183

1138

1.63

8.83

1.5

1.6

g/l

0.3

0.2

1.75

168

1072

(46235355) HIV 1 and 2 tests - Meaningful Use set

891

7316

1.27

8.73

1.9

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

161

973

1.68

8.68

1.7

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

161

974

1.67

8.65

1.4

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.39

8.60

2.2

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

259

2.33

8.59

3.2

2.5

e6/l

553.1

539.5

0.06

217

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

433

3226

1.37

8.55

3.6

3.9

mmol/l

1.2

0.05

388

2809

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4032

38472

1.25

8.49

4.3

3.8

mmol/l

1.4

1.3

18.62

3702

35238

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

186

1178

1.60

8.35

1.5

1.6

g/l

1.2

1.23

175

1109

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

567

4416

1.32

8.35

4.4

4.3

u/l

255.2

243.7

0.63

530

4181

(3014111) Lactate [Moles/volume] in Serum or Plasma

452

3404

1.36

8.35

6.7

7.2

mmol/l

1.4

0.15

428

3276

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

383

2808

1.39

8.34

4.1

3.8

ng/l

95.0

90.4

0.36

323

2406

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

192

1226

1.59

8.33

2.7

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

401

2.04

8.28

5.5

5.2

mmol/l

7.9

7.1

0.95

340

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

315

2236

1.44

8.24

1.5

—

(3021901) Oxygen saturation in Capillary blood

117

656

1.80

8.24

3.4

2.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

156

2.71

8.23

1.1

—

(3003181) Sodium [Moles/volume] in Urine

116

651

1.80

8.15

1.4

mmol/l

62.3

65.0

0.25

522

(3022217) INR in Platelet poor plasma by Coagulation assay

634

5031

1.30

8.13

19.8

24.5

inr

1.2

1.3

3.89

103

733

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

248

2.31

8.04

3.2

2.6

e9/l

0.2

0.02

214

(3023520) Reticulocytes [#/volume] in Blood

417

3129

1.36

7.88

2.6

2.7

e9/l

73.9

70.1

1.19

312

2321

(3009542) Hematocrit [Volume Fraction] of Blood

3941

37603

1.23

7.78

18.1

14.5

39.9

0.13

2768

27738

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

134

796

1.70

7.75

5.1

6.0

iu/ml

528.9

612.6

0.09

109

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

122

2.88

7.73

1.2

2.3

u/ml

575.0

26303.4

—

(3036489) Thrombin time

226

1525

1.50

7.68

2.8

2.0

21.6

21.5

0.11

202

1338

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

224

1512

1.50

7.60

6.0

5.5

1.7

1.6

0.31

213

1407

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

867

7215

1.24

7.47

2.8

3.1

mmol/l

2.5

0.03

737

6320

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.23

7.46

1.1

1.2

—

(3019060) Gas panel - Arterial blood

335

2449

1.39

7.44

6.2

4.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

128

760

1.70

7.43

1.3

1.8

nmol/l

0.9

0.8

0.18

103

646

(3000060) B lymphocytes [#/volume] in Blood

105

2.96

7.22

3.3

2.0

e6/l

97.5

179.6

1.54

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

153

960

1.61

7.19

1.8

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

250

1745

1.46

7.19

3.4

2.7

0.7

0.62

239

1674

(3007930) Methemoglobin/Hemoglobin.total in Blood

219

1492

1.49

7.12

6.1

5.5

0.9

0.15

210

1391

(3007164) IgA [Mass/volume] in Serum or Plasma

913

7682

1.23

7.07

1.7

1.4

g/l

2.4

0.65

587

4687

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

263

2.18

7.04

3.3

2.5

e6/l

640.0

656.8

0.04

110

(3015171) Extractable nuclear Ab [Units/volume] in Serum

216

1474

1.49

6.98

1.2

u/ml

0.4

1.2

1.83

129

(3011397) Hemoglobin [Presence] in Urine by Test strip

1073

9189

1.21

6.97

4.0

3.5

—

(4146454)

386

1.96

6.94

2.9

2.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

428

1.91

6.94

1.2

1.1

iu/ml

1.3

2.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.58

6.92

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

282

2028

1.41

6.91

8.3

10.0

mmol/l

24.1

24.3

0.46

258

1896

(40767503) Oxygen content in Capillary blood by calculation

132

807

1.65

6.89

2.5

2.4

17.0

16.2

1.41

391

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1014

8655

1.22

6.80

1.4

1.2

u/ml

1.7

1.9

0.14

265

2295

(3000991) Gas panel - Venous blood

419

3222

1.33

6.75

8.4

8.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

598

4825

1.27

6.70

1.7

1.8

1.5

1.4

0.27

520

4294

(3008037) Lactate [Moles/volume] in Venous blood

132

815

1.64

6.65

3.4

3.0

mmol/l

1.6

0.06

127

791

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

179

1192

1.52

6.53

1.8

1.6

iu/ml

1.2

0.4

0.45

262

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1198

10428

1.20

6.48

1.7

1.6

mmol/l

1.5

1.4

3.71

985

8772

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

347

1.97

6.48

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

347

1.97

6.48

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

347

1.97

6.48

1.5

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

104

607

1.73

6.48

4.0

3.6

1.1

1.7

1.44

468

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

151

970

1.57

6.47

1.3

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

541

1.77

6.44

1.5

1.4

u/l

28.4

28.9

0.05

449

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.92

6.43

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

180

1206

1.51

6.38

1.3

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.74

6.35

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

205

1419

1.46

6.20

2.2

u/l

4240.5

5469.4

0.29

573

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

135

854

1.60

6.19

2.6

2.4

ug/min

86.4

87.3

0.01

522

(3047181) Lactate [Moles/volume] in Blood

171

1142

1.51

6.17

7.0

6.6

mmol/l

1.3

0.03

152

1000

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

417

1.86

6.17

1.4

1.5

68.6

59.5

1.20

262

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

289

3868

0.73

6.15

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1340

1.47

6.13

2.4

2.2

g/l

2.9

3.1

2.48

147

1058

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

694

1.66

6.10

1.6

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1433

1.46

6.08

2.3

2.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.76

6.08

1.2

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1434

1.46

6.06

2.3

2.2

g/l

7.2

7.4

0.85

149

1080

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1335

1.47

6.06

2.3

2.2

g/l

10.2

10.4

0.25

154

1136

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

217

1529

1.44

5.99

2.3

1.9

ug/l

5.9

2.1

0.89

189

1357

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

215

2.20

5.99

3.1

2.6

41.0

0.00

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

171

1150

1.50

5.98

1.7

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

196

2.26

5.97

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

196

2.26

5.97

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

196

2.26

5.97

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

196

2.26

5.97

1.6

1.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

165

2.37

5.95

1.1

miu/ml

1558.4

1540.2

0.03

165

(3038515) Glucose [Moles/volume] in Venous blood

122

762

1.62

5.91

3.6

3.1

mmol/l

8.2

7.4

1.99

116

742

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1433

1.45

5.91

2.3

2.2

g/l

3.7

3.8

0.74

141

1031

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

166

1113

1.51

5.90

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

367

1.89

5.86

3.7

61.2

57.4

0.57

231

(40761536) Microorganisms panel - Urine sediment

441

3483

1.29

5.86

4.5

3.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

102

610

1.69

5.85

1.8

1.9

mmol/l

1.7

0.37

102

594

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

305

2287

1.36

5.84

1.8

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

478

3822

1.28

5.76

2.5

2.4

u/l

130.3

38.8

0.46

419

3279

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

584

4784

1.25

5.74

8.0

6.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2795

26180

1.15

5.72

3.1

3.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

350

1.90

5.67

1.4

1.3

nmol/l

1.4

1.5

0.06

314

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

104

631

1.66

5.67

1.2

u/ml

4.6

4.2

0.08

208

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

548

1.71

5.65

1.6

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

191

1330

1.45

5.64

5.0

3.8

mmol/l

1.4

0.04

185

1307

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

288

1.99

5.63

1.5

2.2

nmol/l

16.8

18.4

0.78

277

(3021879) Hepatitis B virus core Ab [Presence] in Serum

391

3056

1.30

5.63

1.6

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.29

5.57

1.2

1.7

—

(3025941) Bacteria identified in Stool by Culture

292

2192

1.35

5.57

1.3

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

257

1892

1.38

5.54

5.1

4.1

mmol/l

24.1

0.11

232

1716

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

190

1328

1.45

5.51

2.3

ug/l

617.2

682.1

0.08

178

1254

(3016038) Potassium [Moles/volume] in Urine

237

2.08

5.46

1.2

mmol/l

37.0

35.0

0.28

214

(3037756) Immunofixation for Serum or Plasma

120

764

1.58

5.41

1.7

1.6

—

(40761535) Cells panel - Urine sediment

396

3123

1.29

5.34

3.9

3.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

608

1.64

5.18

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

150

1014

1.49

5.17

1.2

—

(3020891) Body temperature

211

1524

1.40

5.12

6.0

4.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

312

2397

1.32

5.11

1.3

u/ml

200.2

216.4

0.18

287

2207

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

721

6111

1.21

5.11

1.7

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.20

5.08

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

1501

1.40

5.08

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

317

2443

1.32

5.08

3.0

3.3

pmol/l

4.4

4.5

0.32

279

2178

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

401

3190

1.28

5.06

3.0

2.5

ml/min/173m2

64.4

66.5

0.45

178

1244

(3035637) Corticotropin [Mass/volume] in Plasma

478

1.71

4.94

1.3

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

154

1060

1.47

4.88

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

125

2.41

4.79

1.5

1.2

g/l

0.3

0.51

100

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

125

828

1.52

4.78

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

606

1.61

4.77

1.2

u/ml

3.6

4.8

0.59

258

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.17

4.75

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

624

1.60

4.70

1.1

iu/ml

113.0

15706.4

0.53

149

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

156

1085

1.45

4.70

2.4

2.1

g/l

0.1

0.0

0.33

141

996

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

202

1473

1.39

4.67

1.9

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

101

641

1.59

4.67

1.5

1.6

g/l

0.6

0.8

0.74

487

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

259

1.94

4.67

2.0

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

167

1179

1.43

4.64

2.9

3.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

269

2053

1.33

4.64

9.8

10.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

160

1121

1.44

4.64

5.5

4.0

mmol/l

3.9

0.11

149

1048

(3022145) Colonoscopy Study observation

527

4371

1.23

4.63

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

571

4779

1.22

4.60

2.5

2.3

ug/g

156.3

135.9

0.49

452

3776

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

124

828

1.51

4.58

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

166

2.18

4.58

1.6

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

174

1242

1.42

4.56

2.8

2.2

g/l

0.7

1.0

0.75

146

1070

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

468

1.68

4.51

2.3

1.7

titre

13328.0

911.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

401

1.73

4.48

1.4

1.3

g/l

0.3

0.4

2.08

280

(3028192) IgG subclass 2 [Mass/volume] in Serum

401

1.73

4.48

1.4

1.3

g/l

2.2

2.9

4.58

281

(3021387) Prolactin [Units/volume] in Serum or Plasma

190

1382

1.39

4.47

1.8

1.6

mu/l

301.0

294.0

0.10

170

1244

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

562

1.61

4.46

1.7

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

402

1.73

4.45

1.4

1.3

g/l

5.5

6.8

2.51

281

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

189

2562

0.73

4.43

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

517

1.64

4.42

1.5

1.3

—

(3021788) Differential panel - Synovial fluid

102

658

1.56

4.42

1.3

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

216

1608

1.36

4.41

2.1

1.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

533

1.62

4.40

1.6

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

223

1.98

4.39

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

118

2.38

4.39

1.6

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

540

4519

1.22

4.36

2.8

2.9

umol/l

6.9

8.5

1.08

467

3930

(3003338) MCHC [Mass/volume]

3636

34969

1.15

4.35

22.1

17.1

g/l

332.3

332.5

0.50

3614

34688

(3027923) C peptide [Moles/volume] in Serum or Plasma

190

2.06

4.33

1.7

1.4

nmol/l

1.3

1.2

0.29

147

(3028433) Virus identified in Specimen by Culture

138

2.25

4.30

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

526

4397

1.22

4.29

2.1

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

171

2.11

4.27

5.1

12.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

109

720

1.53

4.26

1.9

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

237

1801

1.33

4.24

1.1

titre

55.0

163.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

392

3180

1.25

4.23

3.0

2.9

ng/l

187.4

199.6

0.25

346

2885

(3013139) Helicobacter pylori Ag [Presence] in Stool

327

2598

1.28

4.21

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

234

1.93

4.19

1.1

ratio

1.1

1.0

0.49

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

119

804

1.49

4.19

1.8

1.4

u/ml

31.3

19.7

—

(4035726)

439

3612

1.24

4.18

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

350

1.75

4.17

2.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

127

871

1.47

4.15

1.7

1.6

e6/l

16316.4

14197.0

0.25

615

(4062490)

404

1.69

4.11

1.4

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1131

1.41

4.11

2.3

2.1

g/l

37.9

37.7

0.14

133

974

(3023323) Follitropin [Units/volume] in Serum or Plasma

237

1810

1.32

4.11

1.4

1.3

iu/l

22.1

28.5

2.40

190

1547

(3017446) Testosterone [Moles/volume] in Serum or Plasma

370

2997

1.25

4.06

2.4

2.2

nmol/l

12.2

12.9

0.75

319

2658

(1616796) Gas panel - Central venous blood

124

852

1.47

4.03

3.5

3.8

—

(3019225) pH of Specimen

462

3842

1.22

3.98

4.7

4.2

—

(3017732) Neutrophils [#/volume] in Blood

337

2711

1.26

3.93

3.0

2.8

e9/l

4.0

4.1

0.31

249

2128

(3028707) Methadone [Presence] in Urine by Screen method

622

1.54

3.90

1.8

3.0

—

(4268621)

426

1.65

3.89

2.1

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

262

1.84

3.89

1.1

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

2.10

3.87

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

2.10

3.87

1.7

2.0

—

(44790048)

458

1.62

3.86

1.6

1.5

—

(44806118)

458

1.62

3.86

1.6

1.5

—

(44790047)

458

1.62

3.86

1.6

1.5

—

(44790049)

458

1.62

3.86

1.6

1.5

—

(4306422)

608

1.54

3.85

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

451

1.63

3.83

2.6

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

390

1.68

3.82

4.9

4.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

159

2.08

3.81

1.7

2.0

—

(3039000) Anion gap in Blood

118

813

1.46

3.80

8.5

7.7

mmol/l

11.5

11.3

0.30

110

719

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

142

1013

1.41

3.80

2.5

2.1

g/l

0.0

0.00

127

929

(3018572) Chloride [Moles/volume] in Blood

118

814

1.46

3.78

8.5

7.7

mmol/l

105.1

105.3

0.14

110

720

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

116

800

1.46

3.73

1.9

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

149

1076

1.40

3.72

1.2

titre

156.3

117.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

606

1.53

3.69

1.5

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

107

728

1.48

3.68

1.8

1.4

u/ml

114.9

113.4

0.05

145

(3022313) Gas panel - Capillary blood

223

1717

1.31

3.68

4.5

3.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

379

1.67

3.68

1.4

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

607

1.53

3.67

3.3

3.0

u/ml

53577.4

1601.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

203

1.93

3.66

2.1

1.5

u/l

5.4

7.0

1.03

172

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

450

1.61

3.63

1.5

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.86

3.62

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

609

1.52

3.62

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.43

3.61

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

139

998

1.40

3.60

2.5

2.1

g/l

0.0

0.00

127

929

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

262

1.80

3.59

1.1

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

595

1.52

3.57

1.1

122.5

115.2

1.36

543

(3029634) Reagin Ab [Titer] in Serum by VDRL

547

1.54

3.56

2.8

2.0

titre

2.0

4.4

—

(3008295) Osmolality of Serum or Plasma

398

1.64

3.56

1.4

mosm/kgh2o

276.0

279.3

0.59

318

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

121

850

1.43

3.55

1.5

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

137

2.12

3.54

1.5

2.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

242

1.83

3.51

1.0

1.1

iu/ml

9.0

10.3

0.12

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.16

3.50

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

134

962

1.40

3.49

4.5

4.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

309

1.72

3.49

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

416

1.62

3.48

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

463

1.59

3.48

2.6

2.3

mmol/l

4.0

4.1

0.38

457

(3035285) Chloride [Moles/volume] in Venous blood

463

1.59

3.48

2.6

2.3

mmol/l

105.4

0.01

457

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.55

3.48

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

465

3931

1.20

3.41

2.0

1.9

—

(3004775) Volume in Urine collected for unspecified duration

274

1.76

3.40

2.4

2.2

719.0

621.7

0.82

181

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

610

1.50

3.40

1.1

au/ml

12.4

7.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

115

808

1.43

3.39

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

282

1.74

3.38

1.1

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

149

1098

1.37

3.33

1.3

1.4

ug/g

287.0

282.9

0.10

612

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

161

1.99

3.33

1.9

2.9

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

169

1.96

3.28

1.3

4.8

4.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

135

2.08

3.27

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

185

1415

1.32

3.24

2.4

2.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

109

2.21

3.24

2.3

2.8

umol/l

26.4

29.2

0.52

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

194

1497

1.31

3.20

4.6

3.7

mmol/l

24.8

24.9

0.26

184

1371

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

156

1169

1.35

3.16

3.6

3.3

mg/l

112.5

52.1

0.33

119

934

(3010375) cycloSPORINE [Mass/volume] in Blood

200

1.86

3.15

24.4

25.5

ug/l

111.1

115.4

0.19

165

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.73

3.15

1.5

1.8

ng/l

202.5

124.9

0.40

(3034860) Kappa light chains.free [Mass/volume] in Serum

156

1171

1.34

3.12

3.6

3.3

mg/l

36.0

105.0

0.79

119

936

(3037121) Protein [Mass/volume] in Urine

172

1310

1.32

3.12

3.6

3.3

g/l

0.4

0.3

0.47

562

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

108

763

1.42

3.12

1.3

1.2

u/ml

248.3

266.9

0.28

462

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

152

1138

1.35

3.10

3.5

3.2

ratio

0.9

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.44

3.04

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

643

1.45

3.02

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

112

803

1.40

2.99

3.4

2.9

umol/l

34.4

36.0

0.24

683

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

324

1.64

2.98

1.5

1.4

23.7

29.1

0.51

188

(40760888) Immunoglobulin light chains.free panel - Serum

120

872

1.39

2.96

3.7

3.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

103

730

1.42

2.94

1.6

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

119

866

1.38

2.92

2.1

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

107

765

1.41

2.91

1.2

u/ml

1.3

4.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

440

3761

1.19

2.89

1.8

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

382

1.58

2.88

1.9

2.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

478

1.51

2.87

1.3

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

136

1.99

2.84

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

237

1.74

2.84

1.2

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

480

1.51

2.82

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

472

1.51

2.82

1.3

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

179

1.85

2.81

1.0

1.1

—

(44813793)

276

1.67

2.79

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.45

2.79

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

474

1.51

2.77

1.3

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

849

1.38

2.77

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

475

1.50

2.74

1.3

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

657

1.42

2.73

1.2

1.1

—

(4015189)

2.20

2.73

2.6

2.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

181

1.83

2.73

1.1

u/ml

2.0

6.8

—

(3016879) Cocaine [Presence] in Urine

172

1339

1.29

2.71

1.8

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

182

1.82

2.68

1.2

3.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

486

1.49

2.68

1.3

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

162

1254

1.30

2.67

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

462

1.50

2.67

1.3

1.4

pmol/l

293.1

282.8

0.08

358

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

242

1.70

2.66

1.2

1.4

—

(3011985) Renin [Units/volume] in Plasma

504

1.48

2.64

1.4

mu/l

56.6

52.0

0.11

449

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

297

1.62

2.61

2.1

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

158

1223

1.30

2.61

3.7

2.5

g/l

3.5

3.6

0.07

148

1158

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.55

2.61

1.3

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

516

4511

1.16

2.58

1.6

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

165

1287

1.29

2.58

3.4

2.2

91.7

91.0

0.16

154

1209

(3042631) Mycobacterium sp identified in Specimen

515

1.46

2.57

2.4

2.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1362

12646

1.11

2.56

5.0

4.7

ug/l

2.6

3.2

0.87

1217

11359

(3010421) pH of Blood

138

1053

1.32

2.54

3.5

4.3

7.4

0.30

113

881

(3002256) Pathology report gross observation

604

5352

1.15

2.51

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

333

1.57

2.48

1.5

1.3

e6/l

50325.2

61152.8

0.12

227

(44806071)

2.67

2.45

1.3

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

447

1.48

2.44

1.1

95.9

95.0

0.11

423

(3013727) Leukocytes other/100 leukocytes in Blood

124

1.94

2.40

5.9

3.3

48.8

53.6

0.44

119

(3045142) Bone marrow Pathology biopsy report

458

1.47

2.38

1.2

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.26

2.34

1.0

1.3

—

(40768443) Skin Pathology biopsy report

213

1738

1.24

2.32

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

181

1451

1.26

2.30

1.8

2.0

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.22

2.30

1.9

1.6

mg/l

2.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.22

2.30

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

167

1327

1.27

2.29

3.0

3.2

u/ml

0.4

0.3

0.82

761

(3000093) Morphology [Interpretation] in Blood Narrative

349

1.52

2.26

1.1

—

(3028300) Cannabinoids [Presence] in Urine

181

1455

1.25

2.26

1.8

2.1

—

(3027944) Amphetamines [Presence] in Urine

177

1422

1.25

2.22

1.8

2.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.56

2.21

1.4

1.3

nmol/l

821.4

507.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

148

1165

1.28

2.20

1.7

1.8

nmol/l

42.6

41.4

0.19

141

1131

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

105

789

1.34

2.19

1.2

u/ml

26.4

34.0

0.27

(3012501) Base excess in Blood by calculation

117

895

1.31

2.16

3.8

4.4

mmol/l

2.3

2.7

1.02

603

(3024928) Oxygen saturation in Venous blood

110

835

1.32

2.15

3.8

3.1

—

(3011288) Drugs identified in Urine by Screen method

126

976

1.30

2.13

2.8

3.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.37

2.12

1.7

2.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.05

2.11

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.05

2.11

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.05

2.11

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.05

2.11

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

102

1.96

2.10

1.4

1.2

g/l

44.1

39.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.20

2.09

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.20

2.09

1.1

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

209

1724

1.22

2.08

1.9

1.7

g/l

1.6

1.5

0.12

180

1487

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.14

2.08

1.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.91

2.07

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1090

10115

1.10

2.04

4.1

22.9

21.8

1.51

523

4825

(3023419) Bacteria identified in Sputum by Culture

466

1.42

2.03

2.5

2.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

483

1.41

2.02

1.3

—

(3044941) Cell count panel - Synovial fluid

576

1.38

2.02

1.3

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

517

1.40

2.01

1.9

1.8

89.0

89.6

0.24

510

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

313

2689

1.17

2.01

1.2

iu/ml

187.3

151.7

0.65

120

990

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

811

7421

1.11

2.01

2.9

3.0

ug/l

0.8

0.44

538

4834

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

368

1.47

2.00

4.9

u/ml

128.9

71.9

0.27

102

(3000764) Benzodiazepines [Presence] in Urine

177

1442

1.24

2.00

1.8

2.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.82

2.00

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

246

2073

1.20

1.98

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

142

1.76

1.92

3.2

2.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.05

1.90

1.4

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

128

1.80

1.89

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

324

1.49

1.88

1.4

1.3

mmol/l

13.8

12.2

0.40

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

181

1.66

1.88

6.2

3.3

—

(3022621) pH of Urine by Test strip

296

2548

1.17

1.88

3.2

2.8

—

(36660697) Celiac disease serology panel - Serum

355

3100

1.16

1.87

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

244

1.56

1.86

6.2

6.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

466

1.40

1.86

1.2

1.3

nmol/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

174

1.67

1.85

1.1

90.7

94.4

0.24

139

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

182

1.65

1.84

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

182

1.65

1.84

1.2

1.4

—

(3006270) Folate [Moles/volume] in Blood

342

1.47

1.84

1.2

1.1

nmol/l

377.2

371.4

0.07

297

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.53

1.83

5.0

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

240

2035

1.19

1.83

2.5

2.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

137

1.76

1.83

2.2

3.1

mg/l

6.6

7.9

0.64

113

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

115

1.83

1.82

3.5

3.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

133

1062

1.26

1.82

1.2

1.1

—

(3014271) Vancomycin [Susceptibility]

192

1.62

1.77

2.8

—

(3029075) Extractable nuclear Ab panel - Serum

109

1.84

1.77

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

660

1.32

1.76

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

147

1.70

1.73

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

298

1.48

1.72

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

298

1.48

1.72

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

136

1098

1.25

1.71

4.9

3.5

mg/l

1.6

1.5

0.45

119

1014

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

122

973

1.26

1.70

1.2

1.3

u/ml

3.1

6.3

1.21

151

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

171

1.64

1.70

1.3

1.6

nmol/l

3.2

6.9

0.61

137

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

299

1.48

1.69

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

203

1.58

1.67

9.9

5.6

u/ml

39.2

100.6

0.68

(3039443) Prostate specific Ag panel - Serum or Plasma

831

0.73

1.67

2.0

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

300

1.47

1.67

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

300

1.47

1.67

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

300

1.47

1.67

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

468

1.37

1.66

2.0

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.16

1.66

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

606

1.33

1.66

1.1

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

537

1.35

1.65

1.3

nmol/l

0.1

0.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

487

1.36

1.63

1.2

1.1

—

(3004451) EKG impression Narrative

181

1.61

1.63

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.07

1.59

2.2

1.8

—

(4198724)

159

1.64

1.58

1.5

3.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

139

1137

1.23

1.57

1.7

2.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

120

966

1.25

1.57

1.3

1.2

u/ml

1.8

6.3

0.71

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

222

0.49

1.57

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

284

2477

1.16

1.56

2.3

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

152

1.65

1.56

1.7

2.4

umol/l

46.7

184.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

532

4833

1.11

1.54

5.0

4.3

31.6

32.5

1.08

373

3259

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

130

1.70

1.52

1.1

1.2

93.4

88.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

130

1.70

1.52

2.0

2.6

au/ml

262.5

151.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

115

1.74

1.52

1.5

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

209

1.53

1.51

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

101

1.79

1.48

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.95

1.48

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.81

1.47

1.2

1.1

—

(3014891) Appearance of Pleural fluid

2.22

1.46

1.6

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

132

1.67

1.45

1.1

93.6

89.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.84

1.45

1.0

1.2

pmol/l

302.2

281.6

0.11

(3047189) Immunofixation for 24 hour Urine

179

1.57

1.45

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

179

1.57

1.45

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

576

1.31

1.45

1.3

1.4

nmol/l

0.3

0.4

1.49

447

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

153

1277

1.20

1.44

1.4

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

140

1.65

1.44

1.2

2.1

175.6

169.6

0.11

132

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

140

1.65

1.44

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.73

1.43

1.5

2.0

mg/l

2.4

3.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.97

1.43

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

254

1.46

1.40

1.6

1.4

u/ml

19.7

19.9

—

(3020393) Adenovirus Ag [Presence] in Stool

2.25

1.40

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

247

1.46

1.37

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

182

1.54

1.37

2.4

2.5

—

(3045716) Anion gap in Serum or Plasma

182

1.54

1.37

2.2

mmol/l

8.2

9.4

0.88

144

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.20

1.37

1.2

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.61

1.36

1.0

—

(3008898) HLA-B27 [Presence]

158

1332

1.19

1.36

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.94

1.36

10.8

10.6

—

(3016750) Collection duration of Urine

199

1.51

1.34

2.6

2.2

min

522.6

488.0

1.15

147

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

726

1.26

1.33

1.6

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

103

834

1.24

1.33

1.7

1.9

pmol/l

202.0

200.0

0.07

789

(44806420)

105

1.72

1.33

2.0

2.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.97

1.32

4.7

5.6

—

(3006653) Thiamine [Moles/volume] in Blood

184

1.52

1.31

1.8

1.3

nmol/l

125.2

135.1

0.70

184

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

224

1950

1.16

1.31

2.3

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

292

1.41

1.30

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

331

0.63

1.29

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

267

1.43

1.29

1.4

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

327

1.38

1.27

2.0

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

148

1249

1.19

1.27

1.4

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.09

1.27

1.5

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.05

1.26

1.0

—

(4010399)

302

2691

1.13

1.26

1.5

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

294

1.40

1.26

1.1

1.2

titre

80.0

208.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

691

6429

1.09

1.25

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

1.82

1.25

1.1

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

555

1.28

1.24

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

441

1.32

1.24

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.63

1.21

3.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

842

0.78

1.21

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

443

1.31

1.21

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

197

1.47

1.19

2.0

2.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.31

1.18

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

471

1.30

1.18

2.7

2.1

mg/l

38.3

20.5

1.04

123

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

189

1.48

1.18

1.1

u/l

75.4

79.5

0.14

142

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

189

1.48

1.18

1.1

u/l

17.2

23.7

0.52

140

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

274

1.39

1.15

1.3

1.2

u/ml

72.0

49.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.81

1.15

1.7

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

317

1.36

1.14

1.2

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

465

1.29

1.14

2.3

2.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.69

1.13

1.3

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.85

1.13

4.1

6.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

1.40

1.13

2.0

1.5

—

(3020491) Glucose [Moles/volume] in Blood

275

1.38

1.13

2.6

1.8

mmol/l

6.7

6.5

0.19

184

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

1.12

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

672

1.24

1.11

1.5

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

276

1.38

1.11

1.3

1.2

u/ml

41.0

37.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

476

1.28

1.11

1.8

1.4

ug/l

3.1

4.1

0.68

425

(3051611) Lipemic interference index of Serum or Plasma

397

1.31

1.11

2.9

3.3

—

(3036603) Volume of Urine

251

1.40

1.10

1.5

1761.7

1838.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

389

1.31

1.09

1.2

u/l

42.9

59.5

2.98

261

(3000330) Specific gravity of Urine by Test strip

219

1934

1.14

1.09

4.0

3.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.38

1.09

3.4

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.19

1.08

1.1

1.3

u/l

5.0

20.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

244

1.40

1.07

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.76

1.06

1.7

2.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.65

1.06

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

632

1.24

1.05

1.5

1.2

u/l

30.0

47.4

1.03

545

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.27

1.03

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

2.06

1.02

1.0

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

197

2230

0.88

1.02

1.6

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

117

991

1.18

1.02

1.8

1.9

iu/l

6.2

4.6

0.53

382

(3005033) Fetal Nuchal fold Thickness US

810

0.80

1.02

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

247

1.38

1.01

1.4

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

101

845

1.20

1.01

1.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

2.00

1.00

1.1

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

115

1.57

0.99

1.4

ug/l

9.6

8.8

0.29

115

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.18

0.98

1.4

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.18

0.98

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

275

1.35

0.97

3.0

2.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

124

1062

1.17

0.96

1.1

u/ml

3.4

6.2

0.69

144

(3019977) pH of Arterial blood

207

1.40

0.96

2.6

2.8

7.4

0.42

(3047352) Trisomy 18 risk [Likelihood] in Fetus

813

0.81

0.95

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

210

0.62

0.94

1.2

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.77

0.94

1.0

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

373

1.29

0.93

2.3

2.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

125

1.52

0.93

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

356

1.29

0.92

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

726

1.20

0.91

1.5

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.60

0.90

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

456

1.25

0.89

1.2

1.1

—

(3019174) dRVVT (LA screen)

2.07

0.89

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.91

0.88

1.1

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.61

0.87

1.1

1.3

11.7

32.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.58

0.87

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.86

0.87

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.00

0.87

1.2

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.78

0.84

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.78

0.84

1.0

—

(3025130) Human papilloma virus identified in Specimen

533

1.22

0.83

1.4

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

284

1.31

0.81

2.0

1.7

—

(4034850)

147

1296

1.14

0.81

10.4

8.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

445

1.24

0.80

1.3

1.4

e6/l

3215.1

2126.1

0.40

316

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.79

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.67

0.78

1.1

1.4

—

(40768441) Liver Pathology biopsy report

313

1.28

0.77

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

416

3881

1.08

0.77

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

234

1.33

0.77

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

234

1.33

0.77

1.0

1.1

u/ml

0.2

3.3

—

(1761868) Lipid panel - Serum or Plasma

1440

14868

0.96

0.76

3.0

2.7

—

(3001556) Androgen free Index in Serum or Plasma

1.77

0.76

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.77

0.76

4.3

2.7

u/field

0.3

0.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

235

1.32

0.75

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

438

4100

1.07

0.75

3.4

4.1

ug/l

11.7

24.8

1.28

364

3299

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.60

0.74

1.0

1.1

umol/24h

0.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

307

1.27

0.73

2.0

1.3

promille

1.2

1.3

0.09

237

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

219

1.33

0.73

1.3

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

137

1215

1.13

0.71

1.4

1.3

miu/ml

240.4

225.1

0.19

561

(40768446) Kidney Pathology biopsy report

151

1.39

0.71

1.9

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

573

1.19

0.69

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

283

1.27

0.69

1.9

2.0

u/field

1.1

1.6

0.75

109

(3045414) Leukocytes [Presence] in Urine

193

1751

1.11

0.69

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

213

1.32

0.68

1.5

1.8

—

6.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.46

0.68

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.46

0.68

2.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

393

1.22

0.66

1.1

—

(40768800) Prostate Pathology biopsy report

810

0.85

0.66

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.79

0.66

1.4

1.6

umol/24h

271.2

369.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.79

0.66

1.2

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

403

1.22

0.65

1.3

1.4

e6/l

66119.7

83752.0

0.16

230

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

206

1.31

0.65

1.2

1.3

—

(3045788) Cell count panel - Pleural fluid

350

1.23

0.63

1.4

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

172

1.34

0.63

2.4

umol/l

60.1

55.4

0.21

141

(3034274) Bile acid [Moles/volume] in Serum --fasting

478

1.19

0.63

2.0

2.2

umol/l

6.5

8.3

0.52

335

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

190

1.32

0.62

2.0

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

190

1.32

0.62

2.0

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

270

1.26

0.62

1.0

ng/l

713.1

731.9

0.10

183

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

271

1.26

0.60

1.0

ng/l

311.3

323.6

0.14

188

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1068

0.88

0.60

1.4

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.60

0.0

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.57

0.60

13.8

9.7

mmol/l

7.9

5.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

272

1.25

0.59

1.0

ng/l

40.9

43.7

0.20

185

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

192

1.30

0.59

2.1

2.0

ug/min

98.8

276.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.51

0.58

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1185

11497

1.04

0.58

1.4

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.56

1.3

1.7

umol/l

36.8

40.6

—

(21494755) Public health laboratory ask at order entry panel

392

4149

0.94

0.56

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

124

1.37

0.55

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.45

0.55

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

1.58

0.54

2.2

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

683

1.14

0.54

1.8

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

721

1.14

0.53

2.7

3.1

—

(3024932) HLA-DR beta [Type]

134

1.34

0.53

1.1

—

(3000012) Reticulocyte production index

205

1.27

0.52

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

232

1.25

0.52

2.3

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.50

0.51

2.3

2.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

170

1.30

0.51

2.2

2.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

790

1.13

0.51

1.1

u/ml

1.5

0.01

308

(3012441) Differential panel - Pleural fluid

388

1.19

0.51

1.3

1.5

—

(3024471) HLA-A [Type]

135

1.33

0.51

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.49

0.49

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

661

1.14

0.49

1.4

1.5

—

(1002224) Polysomnography panel

185

1712

1.08

0.48

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

125

1136

1.10

0.48

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

124

1363

0.91

0.48

2.0

1.9

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

108

0.65

0.48

1.0

—

3.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.47

0.47

3.1

2.9

—

(3003129) Base excess in Capillary blood by calculation

1.41

0.46

1.2

1.9

mmol/l

1.4

0.8

0.29

(3022493) Free Hemoglobin [Mass/volume] in Plasma

164

1.28

0.46

5.4

5.8

mg/l

56.7

61.8

0.17

115

(3006462) Nitrate [Presence] in Urine

182

1.26

0.46

3.4

—

(4211845)

200

1.25

0.46

3.7

3.3

—

(3017704) Immunofixation for Urine

191

1.26

0.46

1.3

1.6

—

(3002619) Bacteria identified in Specimen by Culture

1.43

0.45

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

237

1.22

0.45

1.0

1.1

u/ml

0.3

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

894

1.11

0.44

1.5

—

(3042733) HLA Ab [Presence] in Serum

139

1.30

0.43

4.3

4.7

—

(40768795) Lymph node Pathology biopsy report

396

1.16

0.42

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

230

1.22

0.42

2.3

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.64

0.42

3.5

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.64

0.42

7.0

6.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.40

0.42

1.4

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

563

0.87

0.41

1.4

1.3

mmol/l

7.3

0.02

424

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.38

0.41

1.0

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

521

1.13

0.40

1.8

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

278

1.19

0.39

1.3

u/ml

0.6

0.7

0.10

120

(3050794) Legionella sp Ab [Presence] in Serum

1.43

0.39

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.41

0.39

1.3

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.39

0.0

1.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

106

1.32

0.39

1.1

1.4

19.5

22.4

0.14

(40765089) Chromosome analysis panel - Blood by G-banded

106

1.32

0.39

1.0

—

(3024263) Appearance of Synovial fluid

196

1.23

0.39

1.7

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

579

1.12

0.39

4.8

5.3

umol/l

388.8

363.0

0.73

495

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

589

1.12

0.38

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.39

0.38

1.0

1.1

umol/24h

2.8

1.7

—

(3044927) Protein electrophoresis panel - Urine

345

1.16

0.37

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

112

0.71

0.37

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

130

1402

0.93

0.37

1.5

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

514

0.87

0.36

2.4

2.6

13.1

0.16

508

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.29

0.36

1.2

2.9

—

(3051651) Icteric interference index of Serum or Plasma

244

1.19

0.36

3.4

3.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

972

0.91

0.34

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

104

958

1.09

0.34

2.2

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

1.37

0.34

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

836

0.91

0.34

2.9

3.6

u/ml

36.6

681.4

1.39

767

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

971

0.92

0.34

1.3

1.4

—

(4281824)

436

0.87

0.34

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

969

0.92

0.33

1.3

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.30

0.33

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

123

1145

1.08

0.32

1.2

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

164

0.79

0.30

2.2

2.5

nmol/l

253.8

155.8

0.50

143

(3036071) Salmonella sp Ab [Titer] in Serum

142

0.77

0.30

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

859

1.08

0.30

4.3

3.2

mg/l

24.3

26.8

0.23

531

(3044007) Cell count panel - Peritoneal fluid

120

1.25

0.30

1.3

2.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

972

0.92

0.29

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

317

1.14

0.28

1.5

1.4

pmol/l

67.4

160.1

0.47

(42529406) Shigella sp [Presence] in Stool by Culture

123

1154

1.07

0.28

1.2

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.29

0.28

1.1

1.0

ug/l

90.1

79.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

177

1.19

0.27

1.2

—

(4094501)

102

1091

0.93

0.26

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.21

0.26

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.21

0.26

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.21

0.26

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

150

1.20

0.26

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

206

1.17

0.26

1.0

u/ml

0.9

3.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

141

1.21

0.26

1.3

2.2

e6/l

1715.4

681.1

0.42

102

(3000034) Microalbumin [Mass/volume] in Urine

348

1.12

0.25

3.9

3.2

mg/l

82.1

49.1

0.34

265

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.25

0.25

2.0

umol/l

20.2

16.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

368

1.12

0.25

1.2

1.4

mmol/l

6.2

6.5

0.27

340

(3050129) First trimester maternal screen panel - Serum or Plasma

113

1200

0.94

0.24

1.5

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

202

0.84

0.24

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

207

1983

1.05

0.24

1.3

—

(3000492) Spirometry study

396

3845

1.03

0.24

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

265

1.13

0.23

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

641

1.08

0.22

1.0

1.1

u/ml

2.5

2.0

0.10

164

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

2.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

7.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

565

1.08

0.21

1.1

u/ml

3.8

3.1

0.21

274

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.8

—

(3048879) Bone marrow aspiration report

114

0.79

0.20

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

781

1.06

0.20

1.9

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

900

0.94

0.19

2.3

2.1

—

(40768793) Breast Pathology biopsy report

920

0.94

0.18

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

110

1.18

0.17

1.3

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.75

0.17

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

361

0.91

0.17

1.1

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

514

1.07

0.16

1.0

1.1

u/ml

3.9

4.1

0.02

203

(3032773) Endomysium IgG Ab [Titer] in Serum

308

0.91

0.16

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

380

1.08

0.15

2.8

3.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

421

0.93

0.15

1.2

—

(3022689) Creatine [Moles/volume] in Urine

119

0.84

0.15

1.2

1.6

—

(40757373) Influenza virus identified in Isolate

1.14

0.15

1.9

1.7

—

(21494434) Karyotype in Bone marrow

361

1.08

0.15

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.18

0.14

5.3

7.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

112

1.16

0.14

1.0

1.1

u/ml

0.3

10.0

—

(3034426) Prothrombin time (PT)

151

1.13

0.13

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

151

1.13

0.13

1.0

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

213

2076

1.03

0.13

3.4

3.5

u/ml

46.0

57.9

0.53

201

2002

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

238

1.09

0.13

1.4

1.6

u/l

7.7

5.7

—

120

(3003888) Timothy IgE Ab [Units/volume] in Serum

717

1.05

0.12

1.1

u/ml

5.9

5.6

0.03

361

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.18

0.12

1.1

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

559

0.95

0.12

1.0

1.1

u/ml

7.1

3.5

0.44

218

(3002523) Influenza virus A Ag [Presence] in Specimen

630

1.05

0.11

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

105

1.14

0.11

6.0

7.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

632

1.04

0.10

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

251

1.08

0.10

1.4

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

125

1.12

0.10

2.5

2.1

mg/l

8.0

9.5

—

100

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

181

1850

0.98

0.09

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.04

0.09

1.4

1.1

—

(3020650) Glucose [Presence] in Urine

124

0.89

0.09

1.6

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.05

0.08

1.8

1.9

pmol/l

23.9

30.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

175

0.91

0.08

1.9

—

(4024509)

371

1.05

0.08

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.12

0.07

1.5

ug/l

0.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.82

0.07

1.5

1.0

—

8.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

688

1.03

0.07

1.0

1.1

u/ml

2.2

1.3

0.48

283

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

458

0.96

0.07

1.0

u/ml

0.6

0.4

—

111

(40765096) Chromosome analysis panel by Banding

120

1.08

0.04

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

318

1.04

0.04

1.5

g/l

0.9

1.0

0.56

318

(3035933) Granulocytes/100 leukocytes in Blood

121

1.07

0.03

1.2

1.5

—

(40768806) Pleura Pathology biopsy report

401

0.97

0.03

1.5

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

689

1.02

0.02

1.5

—

(4133840)

1.08

0.02

1.3

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

147

0.95

0.01

1.6

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

143

1420

1.01

0.01

2.5

3.5

u/ml

108.8

3959.3

1.23

114

1200

(3027456) Digoxin [Moles/volume] in Serum or Plasma

732

1.01

0.01

3.6

3.1

nmol/l

0.8

0.59

557

(3029396) Erythrocyte agglutination [Presence] in Blood

1.06

0.01

4.4

3.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

106

0.94

0.01

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

286

0.98

0.00

1.6

mmol/l

8.0

7.9

0.10

185

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

128

1.02

0.00

1.1

2.0

e6/l

4567.6

21535.4

—

(3015183) Erythrocyte sedimentation rate

205

0.98

0.00

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

149

1492

1.00

0.00

2.2

1.7

mg/l

3.2

4.1

0.44

104

1040

(3033799) Differential panel - Peritoneal fluid

124

0.97

0.00

1.2

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.03

0.00

1.1

—

(3035880) pH of Pleural fluid

206

1.02

0.00

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

187

1.02

0.00

3.7

3.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

121

0.99

0.00

1.4

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

129

1.01

0.00

1.6

1.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.98

0.00

2.0

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.98

0.00

1.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

121.7

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.97

0.00

1.6

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

99.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3000285) Sodium [Moles/volume] in Blood

1.00

0.00

1.4

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

66.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.1

—

2940.8

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.01

0.00

4.1

7.5

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_BELLPA and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_BELLPA	1.24 [1.13, 1.36]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.21

During the follow-up period (1.1.1998 — 31.12.2019), 2774 out of 16681 females with G6_BELLPA died.

Males

Parameter	HR [95% CI]	p-value
G6_BELLPA	1.149 [1.05, 1.26]	0.004
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 2668 out of 15120 males with G6_BELLPA died.

Mortality risk

Mortality risk for people of age

years, who have G6_BELLPA.

N-year risk	Females	Males
1	0.126%	0.226%
5	0.737%	1.389%
10	1.735%	3.341%
15	3.486%	6.307%
20	5.89%	10.913%

Relationships between endpoints

↥

Index endpoint: G6_BELLPA – Bell's palsy

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bell's palsy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints